CA2179863C - Method and apparatus for endovascular thermal thrombosis and thermal cancer treatment - Google Patents
Method and apparatus for endovascular thermal thrombosis and thermal cancer treatment Download PDFInfo
- Publication number
- CA2179863C CA2179863C CA002179863A CA2179863A CA2179863C CA 2179863 C CA2179863 C CA 2179863C CA 002179863 A CA002179863 A CA 002179863A CA 2179863 A CA2179863 A CA 2179863A CA 2179863 C CA2179863 C CA 2179863C
- Authority
- CA
- Canada
- Prior art keywords
- heating coil
- vascular system
- delivery
- delivery wire
- coil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/08—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by means of electrically-heated probes
- A61B18/082—Probes or electrodes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12136—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
- A61B17/12145—Coils or wires having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00026—Conductivity or impedance, e.g. of tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00292—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
- A61B2017/12054—Details concerning the detachment of the occluding device from the introduction device
- A61B2017/12063—Details concerning the detachment of the occluding device from the introduction device electrolytically detachable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22038—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with a guide wire
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00666—Sensing and controlling the application of energy using a threshold value
- A61B2018/00678—Sensing and controlling the application of energy using a threshold value upper
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00761—Duration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00875—Resistance or impedance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00886—Duration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1226—Generators therefor powered by a battery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1246—Generators therefor characterised by the output polarity
- A61B2018/1253—Generators therefor characterised by the output polarity monopolar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1246—Generators therefor characterised by the output polarity
- A61B2018/126—Generators therefor characterised by the output polarity bipolar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1266—Generators therefor with DC current output
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1435—Spiral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1495—Electrodes being detachable from a support structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3966—Radiopaque markers visible in an X-ray image
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
Abstract
A thrombus is generated in an aneurysm, arteriovenous malformation or fistula by means of a catheter having an insulated heating coil coupled to an insulated delivery wire. In one embodiment, two delivery wires are coupled to heating coils to provide a closed circuit. The heating coils may be in the form of a double helix or a single helix in combination with a straight heating coil. Theheating coils may be permanently connected to the delivery wires or may be electrolytically or mechanically detached therefrom.
Alternatively, a single insulated heating coil may be attached to a single insulated delivery wire with a uninsulated coil attached to the tip of the insulated heating coil. The electrical circuit is then made through the heating coil and non-insulated electrode coil into the vascular system and to a body electrode.
A catheter may also be used for heating blood within the vascular system which is directly flowed into a tumoral mass for the purposes of thermal treatment of cancer.
Alternatively, a single insulated heating coil may be attached to a single insulated delivery wire with a uninsulated coil attached to the tip of the insulated heating coil. The electrical circuit is then made through the heating coil and non-insulated electrode coil into the vascular system and to a body electrode.
A catheter may also be used for heating blood within the vascular system which is directly flowed into a tumoral mass for the purposes of thermal treatment of cancer.
Description
METHOD AND APPARATUS FOR ENDOVASCULAR THERMAL
THROMBOSIS AND THERMAL CANCER TREATMENT
The invention relates to the field of endovascular devices and methodologies and in particular to a means for endovascular heating of blood for purposes of promoting thrombosis in aneurysms, thrombosis in arteriovenous malformations or fistulas, and thermally heating blood in a tumor for consequent destruction of tumoral cells.
THROMBOSIS AND THERMAL CANCER TREATMENT
The invention relates to the field of endovascular devices and methodologies and in particular to a means for endovascular heating of blood for purposes of promoting thrombosis in aneurysms, thrombosis in arteriovenous malformations or fistulas, and thermally heating blood in a tumor for consequent destruction of tumoral cells.
2~?9863 2. Description of the PriorArt Approximately 25,000 intracranial aneurysms rupture every year in North America. The primary purpose of treatment for ruptured intracranial aneurysm is to prevent rebleeding. At the present time, three general methods of treatment exist, namely an extravascular, endovascular and extra-endovascular approach.
The extravascular approach is comprised of surgery or microsurgery of the aneurysm or treatment site for the purpose of preserving the parent artery.
This treatment is common with intracranial berry aneurysms. The methodology comprises the step of clipping the neck of the aneurysm, performing a suture-ligation of the neck, or wrapping the entire aneurysm. Each of these surgical procedures is performed by intrusive invasion into the body and performed from outside the aneurysm or target site. General anesthesia, craniotomy, brain retraction and arachnoid dissection around the neck of the aneurysm and placement of a clip are typically required in these surgical procedures. Surgical treatment of vascular intracranial aneurysm can expect a mortality rate of 4-8% with a morbidity rate of 18-20%. Because of the mortality and morbidity rate expected, the surgical procedure is often delayed while waiting for the best surgical time with the result that an additional percentage of patients will die from the underlying disease or defect prior to surgery. For this reason the prior art has sought alternative means of treatment.
In the endovascular approach, the interior of the aneurysm is entered through the use of a microcatheter. Recently developed microcatheters, such as those shown by Engleson, "Catheter Guidewire ; U.S. Patent 4,884,579 and as described in Engleson, "Catheter for Guidewire Tracking ; U.S. Patent 4,739,768 (1988), allow navigation into the cerebral arteries and entry into a cranial aneurysm.
In such procedures a balloon is typically attached to the end of the microcatheter and it is possible to introduce the balloon into the aneurysm, inflate it, and detach it, leaving it to occlude the sac and neck with preservation of the parent artery. While endovascular balloon embolization of berry aneurysms is an attractive method in situations where an extravascular surgical approach is difficult, inflation of a balloon into the aneurysm carries some risk of aneurysm rupture due to possible over-distention of portions of the sac and due to the traction produced while detaching the balloon.
While remedial procedures exist for treating a ruptured aneurysm during classical extravascular surgery, no satisfactory methodology exists if the aneurysm breaks during an endovascular balloon embolization.
Furthermore, an ideal embolizing agent should adapt itself to the irregular shape of the internal walls of the aneurysm. On the contrary, in a balloon embolization the aneurysmal wall must conform to the shape of the balloon.
This may not lead to a satisfactory result and further increases the risk of rupture.
Still further, balloon embolization is not always possible. If the diameter of the deflated balloon is too great to enter the intracerebral arteries, especially in the cases where there is a vasospasm, complications with ruptured intracranial aneurysms may occur. The procedure then must be deferred until the spasm is resolved and this then incurs a risk of rebleeding.
In the extra-intravascular approach, an aneurysm is surgically exposed or stereotaxically reached with a probe. The wall of the aneurysm is then perforated from the outside and various techniques are used to occlude the interior in order to r 2179~b3 prevent it from rebleeding. These prior art techniques include electrothrombosis, isobutyl-cyanoacrylate embolization, hog-hair embolization and ferromagnetic thrombosis.
In the use of electrothrombosis for extra-intravascular treatment the tip of a S positively charged electrode is inserted surgically into the interior of the aneurysm.
An application of the positive charge attracts white blood cells, red blood cells, platelets and fibrinogen which are typically negatively charged at the normal pH of the blood. The thrombic mass is then formed in the aneurysm about the tip.
Thereafter, the tip is removed. See Mullan, 'Experiences with Surgical Thrombosis of Intraam:ial Berry Aneurysms and Carotid Cavernous Flrtulas ; J. Neurosurg., Vol. 41, December 1974; Hosobuchi, "Electrothrombosis Carotid-Cavernous Fistula ; J.
Neurosurg., Vo142, January 1975; Arala et al., "Electrically Induced Thrombosis for the Treatment of Intracranial Aneurysms and Angiomas ; Excerpta Medica International Congress Series, Amsterdam 1965, Vol. 114, 651-654; Sawyer et aL, "Bio-Electric Phenomena as an Etiological Factor in Intravascular Thrombosis ;
Am. J.
Physiol., VoL 175, 103-107 (1953); J. Piton et aL, "Selective Vascular Thrombosis Induced by a Direct Electrical Current; Animal Experimerr~s ; J.
Neuroradiology, VoL
S, pages 139-152 (1978). However, each of these techniques involves some type of intrusive procedure to approach the aneurysm from the exterior of the body.
The prior art has also devised the use of a liquid adhesive, isobutyl-cyanoacrylate (IBCA) which polymerizes rapidly on contact with blood to form a firm mass. The liquid adhesive is injected into the aneurysm by puncturing the sac with a small needle. In order to avoid spillage into the parent artery during IBCA
injection, blood flow through the parent artery must be momentarily reduced or interrupted. Alternatively, an inflated balloon may be placed in the artery at the level of the neck of the aneurysm for injection. In addition to the risks caused by temporary blockage of the parent artery, the risks of seepage of such a polymerizing adhesive into the parent artery exists, if it is not completely blocked with consequent occlusion of the artery.
Still further, the prior art has utilized an air gun to inject hog hair through the aneurysm wall to induce internal thrombosis. The success of this procedure involves exposing the aneurysm sufficiently to allow air gun injection and has not been convincingly shown as successful for thrombic formations.
Ferromagnetic thrombosis in the prior art in extra-intravascular treatments comprises the stereotactic placement of a magnetic probe against the sac of the aneurysm followed by injection into the aneurysm by an injecting needle of iron microspheres. Aggregation of the microspheres through the extravascular magnet is followed by interneuysmatic thrombus. This treatment has not been entirely successful because of the risk of fragmentation of the metallic thrombus when the extravascular magnet is removed. Suspension of the iron powder in methyl methylmethacrylate has been used to prevent fragmentation. The treatment has not been favored, because of the need to puncture the aneurysm, the risk of occlusion of the parent artery, the use of unusual and expensive equipment, the need for a craniectomy and general anesthesia, and the necessity to penetrate cerebral tissue to reach the aneurysm.
Endovascular coagulation of blood is also well known in the art and a device using laser optically generated heat is shown by O'Reilly, "Optical Fiber with Attachable Metallic Tip for Intravascular Laser Coagulation of Arteries, Veins, Aneurysms, Vascular Malformation and Arteriovenous Fistulas ; U.S. Patent 4,735,201 (1988). See also, O'ReiUy et al., "Laser Induced Thermal Occlusion of Berry 21 .7965 Aneurysms: Initial Experimental Results ; Radiology, Vol. 171, No. 2, pages (1989). O'Reilly places a tip into an aneurysm by means of an endovascular microcatheter. The tip is adhesively bonded to a optic fiber disposed through the microcatheter. Optical energy is transmitted along the optic fiber from a remote laser at the proximal end of the microcatheter. The optical energy heats the tip to cauterize the tissue surrounding the neck of the aneurysm or other vascular opening to be occluded. The catheter is provided with a balloon located on or adjacent to its distal end to cut off blood flow to the site to be cauterized and occluded.
Normally, the blood flow would carry away the heat at the catheter tip, thereby preventing cauterization. The heat in the tip also serves to melt the adhesive used to secure the tip to the distal end of the optical fiber. If all goes well, the tip can be separated from the optical fiber and left in place in the neck of the aneurysm, provided that the cauterization is complete at the same time as the hot melt adhesive melts.
A thrombus is not formed from the heated tip. Instead, blood tissue surrounding the tip is coagulated Coagulation is a denaturation of protein to form a connective-like tissue similar to that which occurs when the albumen of an egg is heated and coagulates from a clear running liquid to an opaque white solid.
The tissue characteristic and composition of the coagulated tissue is therefore substantially distinct from the thrombosis which is formed by the thrombotic aggregation of white and red blood cells, platelets and fibrinogen. The coagulative tissue is substantially softer than a thrombic mass and can therefore more easily be dislodged.
O'Reiilly's device depends at least in part upon the successful cauterization timed to occur no later than the detachment of the heat tip from the optic fiber.
The heated tip must also be proportionally sized to the neck of the aneurysm in order to effectively coagulate the tissue surrounding it to form a blockage at the neck. It is believed that the tissue in the interior of the aneurysm remains substantially uncoagulated. In addition, the hot melt adhesive attaching the tip to the optic fiber melts and is dispersed into the adjacent blood tissue where it resolidifies to form free particles within the intracranial blood stream with much the same disadvantages which result from fragmentation of a ferromagnetic electrothrombosis.
Therefore, what is needed is an apparatus and methodology which avoids each of the shortcomings and limitations of the prior art discussed above.
Brief Summary of the Invention The invention is an improvement in a catheter for use within a vascular system. The improvement comprises at least one delivery wire. At least one heating coil is coupled to the delivery wire. The delivery wire and heating coil are both electrically insulated to permit endovascular disposition of the delivery wire and heating coil into the vascular system for the purpose of delivering heat to a fluid within the vascular system at a predetermined location. Substantially all of the heat is generated by electrical current flowing within the heating coil rather than within the delivery wire, because of the greater electrical resistance of the heating coil. As a result, endovascular thermal treatment is provided within the vascular system.
The delivery wire and heating coil are temporarily coupled to each other and can be selectively detached. In the preferred embodiment the delivery wire and heating coil are electrolytically detachable from each other. However, the delivery wire and heating coil may also be mechanically detachable from each other.
The extravascular approach is comprised of surgery or microsurgery of the aneurysm or treatment site for the purpose of preserving the parent artery.
This treatment is common with intracranial berry aneurysms. The methodology comprises the step of clipping the neck of the aneurysm, performing a suture-ligation of the neck, or wrapping the entire aneurysm. Each of these surgical procedures is performed by intrusive invasion into the body and performed from outside the aneurysm or target site. General anesthesia, craniotomy, brain retraction and arachnoid dissection around the neck of the aneurysm and placement of a clip are typically required in these surgical procedures. Surgical treatment of vascular intracranial aneurysm can expect a mortality rate of 4-8% with a morbidity rate of 18-20%. Because of the mortality and morbidity rate expected, the surgical procedure is often delayed while waiting for the best surgical time with the result that an additional percentage of patients will die from the underlying disease or defect prior to surgery. For this reason the prior art has sought alternative means of treatment.
In the endovascular approach, the interior of the aneurysm is entered through the use of a microcatheter. Recently developed microcatheters, such as those shown by Engleson, "Catheter Guidewire ; U.S. Patent 4,884,579 and as described in Engleson, "Catheter for Guidewire Tracking ; U.S. Patent 4,739,768 (1988), allow navigation into the cerebral arteries and entry into a cranial aneurysm.
In such procedures a balloon is typically attached to the end of the microcatheter and it is possible to introduce the balloon into the aneurysm, inflate it, and detach it, leaving it to occlude the sac and neck with preservation of the parent artery. While endovascular balloon embolization of berry aneurysms is an attractive method in situations where an extravascular surgical approach is difficult, inflation of a balloon into the aneurysm carries some risk of aneurysm rupture due to possible over-distention of portions of the sac and due to the traction produced while detaching the balloon.
While remedial procedures exist for treating a ruptured aneurysm during classical extravascular surgery, no satisfactory methodology exists if the aneurysm breaks during an endovascular balloon embolization.
Furthermore, an ideal embolizing agent should adapt itself to the irregular shape of the internal walls of the aneurysm. On the contrary, in a balloon embolization the aneurysmal wall must conform to the shape of the balloon.
This may not lead to a satisfactory result and further increases the risk of rupture.
Still further, balloon embolization is not always possible. If the diameter of the deflated balloon is too great to enter the intracerebral arteries, especially in the cases where there is a vasospasm, complications with ruptured intracranial aneurysms may occur. The procedure then must be deferred until the spasm is resolved and this then incurs a risk of rebleeding.
In the extra-intravascular approach, an aneurysm is surgically exposed or stereotaxically reached with a probe. The wall of the aneurysm is then perforated from the outside and various techniques are used to occlude the interior in order to r 2179~b3 prevent it from rebleeding. These prior art techniques include electrothrombosis, isobutyl-cyanoacrylate embolization, hog-hair embolization and ferromagnetic thrombosis.
In the use of electrothrombosis for extra-intravascular treatment the tip of a S positively charged electrode is inserted surgically into the interior of the aneurysm.
An application of the positive charge attracts white blood cells, red blood cells, platelets and fibrinogen which are typically negatively charged at the normal pH of the blood. The thrombic mass is then formed in the aneurysm about the tip.
Thereafter, the tip is removed. See Mullan, 'Experiences with Surgical Thrombosis of Intraam:ial Berry Aneurysms and Carotid Cavernous Flrtulas ; J. Neurosurg., Vol. 41, December 1974; Hosobuchi, "Electrothrombosis Carotid-Cavernous Fistula ; J.
Neurosurg., Vo142, January 1975; Arala et al., "Electrically Induced Thrombosis for the Treatment of Intracranial Aneurysms and Angiomas ; Excerpta Medica International Congress Series, Amsterdam 1965, Vol. 114, 651-654; Sawyer et aL, "Bio-Electric Phenomena as an Etiological Factor in Intravascular Thrombosis ;
Am. J.
Physiol., VoL 175, 103-107 (1953); J. Piton et aL, "Selective Vascular Thrombosis Induced by a Direct Electrical Current; Animal Experimerr~s ; J.
Neuroradiology, VoL
S, pages 139-152 (1978). However, each of these techniques involves some type of intrusive procedure to approach the aneurysm from the exterior of the body.
The prior art has also devised the use of a liquid adhesive, isobutyl-cyanoacrylate (IBCA) which polymerizes rapidly on contact with blood to form a firm mass. The liquid adhesive is injected into the aneurysm by puncturing the sac with a small needle. In order to avoid spillage into the parent artery during IBCA
injection, blood flow through the parent artery must be momentarily reduced or interrupted. Alternatively, an inflated balloon may be placed in the artery at the level of the neck of the aneurysm for injection. In addition to the risks caused by temporary blockage of the parent artery, the risks of seepage of such a polymerizing adhesive into the parent artery exists, if it is not completely blocked with consequent occlusion of the artery.
Still further, the prior art has utilized an air gun to inject hog hair through the aneurysm wall to induce internal thrombosis. The success of this procedure involves exposing the aneurysm sufficiently to allow air gun injection and has not been convincingly shown as successful for thrombic formations.
Ferromagnetic thrombosis in the prior art in extra-intravascular treatments comprises the stereotactic placement of a magnetic probe against the sac of the aneurysm followed by injection into the aneurysm by an injecting needle of iron microspheres. Aggregation of the microspheres through the extravascular magnet is followed by interneuysmatic thrombus. This treatment has not been entirely successful because of the risk of fragmentation of the metallic thrombus when the extravascular magnet is removed. Suspension of the iron powder in methyl methylmethacrylate has been used to prevent fragmentation. The treatment has not been favored, because of the need to puncture the aneurysm, the risk of occlusion of the parent artery, the use of unusual and expensive equipment, the need for a craniectomy and general anesthesia, and the necessity to penetrate cerebral tissue to reach the aneurysm.
Endovascular coagulation of blood is also well known in the art and a device using laser optically generated heat is shown by O'Reilly, "Optical Fiber with Attachable Metallic Tip for Intravascular Laser Coagulation of Arteries, Veins, Aneurysms, Vascular Malformation and Arteriovenous Fistulas ; U.S. Patent 4,735,201 (1988). See also, O'ReiUy et al., "Laser Induced Thermal Occlusion of Berry 21 .7965 Aneurysms: Initial Experimental Results ; Radiology, Vol. 171, No. 2, pages (1989). O'Reilly places a tip into an aneurysm by means of an endovascular microcatheter. The tip is adhesively bonded to a optic fiber disposed through the microcatheter. Optical energy is transmitted along the optic fiber from a remote laser at the proximal end of the microcatheter. The optical energy heats the tip to cauterize the tissue surrounding the neck of the aneurysm or other vascular opening to be occluded. The catheter is provided with a balloon located on or adjacent to its distal end to cut off blood flow to the site to be cauterized and occluded.
Normally, the blood flow would carry away the heat at the catheter tip, thereby preventing cauterization. The heat in the tip also serves to melt the adhesive used to secure the tip to the distal end of the optical fiber. If all goes well, the tip can be separated from the optical fiber and left in place in the neck of the aneurysm, provided that the cauterization is complete at the same time as the hot melt adhesive melts.
A thrombus is not formed from the heated tip. Instead, blood tissue surrounding the tip is coagulated Coagulation is a denaturation of protein to form a connective-like tissue similar to that which occurs when the albumen of an egg is heated and coagulates from a clear running liquid to an opaque white solid.
The tissue characteristic and composition of the coagulated tissue is therefore substantially distinct from the thrombosis which is formed by the thrombotic aggregation of white and red blood cells, platelets and fibrinogen. The coagulative tissue is substantially softer than a thrombic mass and can therefore more easily be dislodged.
O'Reiilly's device depends at least in part upon the successful cauterization timed to occur no later than the detachment of the heat tip from the optic fiber.
The heated tip must also be proportionally sized to the neck of the aneurysm in order to effectively coagulate the tissue surrounding it to form a blockage at the neck. It is believed that the tissue in the interior of the aneurysm remains substantially uncoagulated. In addition, the hot melt adhesive attaching the tip to the optic fiber melts and is dispersed into the adjacent blood tissue where it resolidifies to form free particles within the intracranial blood stream with much the same disadvantages which result from fragmentation of a ferromagnetic electrothrombosis.
Therefore, what is needed is an apparatus and methodology which avoids each of the shortcomings and limitations of the prior art discussed above.
Brief Summary of the Invention The invention is an improvement in a catheter for use within a vascular system. The improvement comprises at least one delivery wire. At least one heating coil is coupled to the delivery wire. The delivery wire and heating coil are both electrically insulated to permit endovascular disposition of the delivery wire and heating coil into the vascular system for the purpose of delivering heat to a fluid within the vascular system at a predetermined location. Substantially all of the heat is generated by electrical current flowing within the heating coil rather than within the delivery wire, because of the greater electrical resistance of the heating coil. As a result, endovascular thermal treatment is provided within the vascular system.
The delivery wire and heating coil are temporarily coupled to each other and can be selectively detached. In the preferred embodiment the delivery wire and heating coil are electrolytically detachable from each other. However, the delivery wire and heating coil may also be mechanically detachable from each other.
The im~?rovement further comprises at least two delivery wires and at least two heating coils, each having a proximal and distal end. The proximal end of each of the heating coil; is coupled to corresponding ones of the two delivery wires. The distal end of the two heating coils is coupled together to provide a continuous circuit through a first one of the two delivery wires to a first one of the two heating coils, to a second one of the two heating coils, and to a se,~ond one of the two delivery wires.
In the illustrated embodiment the two heating coils are each helical and together form a double helical tip.
In another embodiment one of the two delivery wires is helical and the other one of the two delivery wires is non-helical.
In another embodiment the improvement further comprises a body electrode in electrical circuit with the vascular system. The heating coil has a proximal and distal end. The proximal end is coupled to the delivery wire and further comprises a uninsul.ated coil coupled to the distal end of the heating coil. The electrical resistance of: the uninsulated coil is less than the heating coil so that substantially all of the heat generated by the current is c~enerat:ed within the insulated heating coil.
The uninsulat:ed coil serves as an endovascular electrode to provide completion of circuit through the delivery wire, and heating coil to the body electrode.
The improvement further comprises a current source coupled to the de7_ivery wire for controllably delivering the electrical current thereto.
Accordingly, the present invention provides an improvement in an endovascular device for use within a vascular system comprising:
at leasi~ one elongate, flexible, fully insulated and substantially unsupported delivery wire having a first resistance; and at least one elongate, flexible, fully insulated, substantiall;r unsupported, and longitudinally resilient heating coil having a second resistance coupled to said delivery wire, said first resistance being less than said second resisl~ance, wherein said delivery wire and heating coil are botr.electrically insulated to permit endovascular disposition of said delivery wire and heating coil into said vascular system to deliver heat to blood within said vascular system at a predetermined location, substantially all of said heat being generated by electrical current flowing within said heating coil rather than within said delivery wire;
whereby endovascular thermal treatment is provided within said ~rascular system.
In a further aspect, the present invention provides an improvement in an endovascular device for use within a vascular system comprising:
at least. one delivery wire having a first resistance;
at leasi~ one heating coil having a second resistance coupled to s~rid de:Livery wire, said first resistance being less than said second resistance, wherein said delivery wire and heating coil are both electrically insulated to permit endovascular disposition of said delivery wire and heating coil into said vascular system to deliver heat to a fluid within said vascular system at a predetermined location, sux>stant_Lally all of said heat being generated by electrical current flowing within said heating coil rather than within raid delivery wire; and at leasi~ two delivery wires and at least two heating coils each h~~ving <~ proximal and distal end, said proximal end of eacr, of said heating coils being coupled to corresponding ones of said two delivery wires, said distal end of said two heating coils being coupled together to provide a continuous circuit through a ffirst one of said two delivery wire; to a first one of said two heating coils, to a ~>econd one of said two heating coils, and to a second one oj= said two delivery wires;
whereby endovascular thermal treatment is provided within said ~rascular system.
In the illustrated embodiment the two heating coils are each helical and together form a double helical tip.
In another embodiment one of the two delivery wires is helical and the other one of the two delivery wires is non-helical.
In another embodiment the improvement further comprises a body electrode in electrical circuit with the vascular system. The heating coil has a proximal and distal end. The proximal end is coupled to the delivery wire and further comprises a uninsul.ated coil coupled to the distal end of the heating coil. The electrical resistance of: the uninsulated coil is less than the heating coil so that substantially all of the heat generated by the current is c~enerat:ed within the insulated heating coil.
The uninsulat:ed coil serves as an endovascular electrode to provide completion of circuit through the delivery wire, and heating coil to the body electrode.
The improvement further comprises a current source coupled to the de7_ivery wire for controllably delivering the electrical current thereto.
Accordingly, the present invention provides an improvement in an endovascular device for use within a vascular system comprising:
at leasi~ one elongate, flexible, fully insulated and substantially unsupported delivery wire having a first resistance; and at least one elongate, flexible, fully insulated, substantiall;r unsupported, and longitudinally resilient heating coil having a second resistance coupled to said delivery wire, said first resistance being less than said second resisl~ance, wherein said delivery wire and heating coil are botr.electrically insulated to permit endovascular disposition of said delivery wire and heating coil into said vascular system to deliver heat to blood within said vascular system at a predetermined location, substantially all of said heat being generated by electrical current flowing within said heating coil rather than within said delivery wire;
whereby endovascular thermal treatment is provided within said ~rascular system.
In a further aspect, the present invention provides an improvement in an endovascular device for use within a vascular system comprising:
at least. one delivery wire having a first resistance;
at leasi~ one heating coil having a second resistance coupled to s~rid de:Livery wire, said first resistance being less than said second resistance, wherein said delivery wire and heating coil are both electrically insulated to permit endovascular disposition of said delivery wire and heating coil into said vascular system to deliver heat to a fluid within said vascular system at a predetermined location, sux>stant_Lally all of said heat being generated by electrical current flowing within said heating coil rather than within raid delivery wire; and at leasi~ two delivery wires and at least two heating coils each h~~ving <~ proximal and distal end, said proximal end of eacr, of said heating coils being coupled to corresponding ones of said two delivery wires, said distal end of said two heating coils being coupled together to provide a continuous circuit through a ffirst one of said two delivery wire; to a first one of said two heating coils, to a ~>econd one of said two heating coils, and to a second one oj= said two delivery wires;
whereby endovascular thermal treatment is provided within said ~rascular system.
The present invention also provides a microcatheter for selectively heating tissue at a predetermined location within a vascular system where said microcatheter is disposed within said vascular system at said predetermined location, said m:icrocatheter comprising at least one insulated heating coil disposed by said microcatheter at said predetermined location, said insulated heating coil being electrically coupled to an insulated delivery wire included within said microcatheter and extending exteriorly to said vascular system, wherein electrical current is applied through said delivery wire to said heating coil to heat blood within said vascular system at said predetermined location to thermally heat tissue in contact with said blood; and after which said microcatheter and delivery wire is withdrawn from said vascular system.;
whereby thermal heating of tissue within said vascular system is se=Lectively formed.
The present invention also provides a microcatheter for treating cancer where said microcatheter is disposed within said ~rascular system at a predetermined location in a blood flo~ni to a. tumoral mass, at least one insulated heating coil which is electrically coupled to an insulated delivery wire included within said microcatheter and extending exteriorly to said vascular system, wherein an electrical current is applied through said delivery wire to said heating coil to hat said blood flow within said vascular system at said predetermined location to thermally stress said t:umoral mass downstream;
whereby thermal treatment of said tumoral mass is effected.
In a ~~till further aspect the present invention provides an ~=ndovascular device for use within a vascular system compr_LSing at least= one delivery wire having a first resistance;
and at leash one detachable heating coil having a second resistance coupled to said delivery wire, said first resistance being lr=_ss than said second resistance, wherein 9a said deliver~~ wire and heating coil are both electrically insulated to permit endovascular disposition of said delivery wire and heating coil into said vascular system for the purpose of delivering heat to a fluid within said vascular syst:em at a predetermined location, substantially all of said heat being generated by electrical current flowing within said heating coil rather than within said delivery wire;
whereby endovascular thermal treatment is provided within said ~rascular system.
The present invention also provides a microcatheter for forming <~ thrombus at a predetermined location within a vascular ;system where said microcatheter is disposed within said zTascular system at said predetermined location with at least one insulated heating coil, said insulated heating coil being electrically coupled to an insulated delivery wire included within said microcatheter and extending ext:erior:iy to said vascular system, so that when electrical current is applied through said delivery wire to said heating coil fluid is heated within said vascular system at said predetermined location to thermally form a thrombus thereat, after which said delivery wire is detached from said heating coil, and said microcatheter and delivery wire is withdrawn from said vascular system;
whereby thermal formation of a thrombus within said vascular system is selectively formed.
9b The invention and its various embodiments may be better visualized by turning to the following drawings wherein like elements are referenced by like numerals.
Brief Description of the Drawings Figure 1 is a simplified diagrammatic side view of a catheter tip embodying the present invention.
Figure 2 is a simplified diagrammatic side view of a second embodiment of the invention.
Figure 3 is a simplified diagrammatic side view of a third embodiment of the invention.
Figure 4 is a simplified view of a fourth embodiment of the invention.
Figure 5 is an idealized diagram showing the placement of a catheter utilizing on of the embodiments of the invention within a vascular aneurysm.
Figure 6 is a diagrammatic view of another embodiment of the invention showing utilization for cancei treatment.
Figure 7a is a simplified cross sectional side view of an embodiment for use in a second technique in which the invention may be practiced.
Figure 7b is a simplified side view of a catheter tip illustrated in a second embodiment also used in the second technique of the invention.
Figure 8 is a simplified diagrammatic view which shows a source having a DC
generator and an AC or RF generator coupled through a single pole, double throw switch to the delivery wire.
The invention and its various embodiments may now be understood by turning to the following detailed description.
21~98b3 Detailed Description of the Preferred Embodiments A clot is generated in an aneurysm, arteriovenous malformation or fistula by means of a catheter having an insulated heating coil coupled to an insulated delivery wire. In one embodiment, two delivery wires are coupled to heating coils to provide a closed circuit. The heating coils may be in the form of a double helix or a single helix in combination with a straight heating coil. The heating coils may be permanently connected to the delivery wires or may be electrolytically or mechanically detached therefrom.
Alternatively, a single insulated heating coil may be attached to a single insulated delivery wire with a uninsulated coil attached to the tip of the insulated heating coil. The electrical circuit is then made through the heating coil and non-insulated electrode coil into the vascular system and to a body electrode.
A catheter may also be used for heating blood within the vascular system which is directly flowed into a tumoral mass for the purposes of thermal treatment of cancer.
There are two main ways in which the goal of thermal thrombosis can be achieved in the invention, the first of which is illustrated in connection with Figures 1-6, which use some form of a double wire or closed circuit loop, and the second of which is illustrated in connection with the catheter tips shown in Figures 7a and 7b which uses some form of a single wire or body circuit loop.
Within each of these techniques, the invention may be practiced using a plurality of different embodiments or modifications. Further, the catheter tips of the methodology of the invention can be further be used not only for the promotion of clotting in aneurysms, arteriovenous malformations of fistulas, but also in therapeutic treatment of tumoral cells.
Consider first the first technique of endovascular promotion of the formation of clots as illustrated in Figures 1-5. As shown in Figure 1, a catheter, generally denoted by reference numeral 10, is provided with two insulated stainless steel delivery wires 12 and 14 covered by insulating jackets 16. Additional catheter elements as are now known or later developed in the art may be included in the actual structure of the catheter, which is used. Delivery wires 12 and 14 are shown in isolation of the catheter assembly per se inasmuch as the remaining catheter structure is conventional and largely immaterial to the operation of the invention.
However, it must be clearly understood that the delivery wires 12 and 14 are not necessarily disposed in the vascular system as a pair of associated wires as the simplified diagrammatic side views of Figures 1-4 might suggest. Instead, wires 12 and 14 would be appropriately included within a delivery or guide catheter of conventional design, which is symbolically denoted in Figure 5 by reference numeral 22. Wires 12 and 14 could be coaxial.
Delivery wire 12 terminates at an end 18 of its insulating jacket 16 and is coupled at or near end 18 to a Teflon insulated platinum helix 20. The diameter of platinum helix 20 is typically in the range of 0.1 to 0.5 millimeters and may be comprised of a tight helical platinum wire, which when extended from the end of delivery catheter 22 as shown in Figure 5, forms itself into a helical envelope as depicted by the large helical form in Figures 1-4.
Similarly, stainless steel delivery wire 14 terminates at its end 24 by connection to a Teflon insulated platinum helical coil 26 which, when released, also extends in the embodiment of Figure 1 as a helix. Coils 20 and 26 thus form a pair of helical coils similar in gross geometry to the double helical coil of a DNA
molecule. Helical coils 20 and 26 are coupled together at their distal ends 30, or may be fabricated from a single integral strand of coil, which is then bent or turned at end 30.
The connection between delivery wires 12 and 14 and helical coils 20 and 26, respectively, in the embodiment of Figure 1 is by means of a permanent solder joint, although other types of mechanical and electrical connections are contemplated, some of which are described in the embodiments of Figures 2-4.
Further, in addition to generally forming a helical envelope as shown in Figure 1, platinum coils 20 and 26 may be entirely or substantially limp, or without defined or prebiased form, so that a loose bird nest's configuration is formed by the released coils 20 and 26 as opposed to the tendency to form DNA-like double helix coil structures as shown in the embodiment of Figure 1. In other words, coils 20 and 26 may or may not retain some type of geometric association with each other after being disposed out of the end of catheter 22 depending on the embodiment utilized.
The electrical resistance of platinum or the platinum tungsten alloy from which coils 20 and 26 are fabricated is typically much higher than that of the stainless steel delivery wires which comprise wires 12 and 14. Therefore, it is possible to apply an electrical current to the double helical tip 28, which is comprised of coils 20 and 26, to selectively cause tip 28 to thermally heat with substantially no heat produced in delivery wires 12 and 14, because of the large disparity in the resistance between the two.
The electrical current applied to coil tip 28 through delivery wires 12 and 14 may be a DC current, alternating current, a radiofrequency power signal or any combination of the same. Regardless of the frequency of the electrical current, the current signal may have any envelope desired or be modulated in any way desired including modulation in the form of sin waves, square waves, triangular waves, pulsed, continuous or the like.
Coils 20 and 26 are Teflon coated or provided with another biologically nontoxic insulating material to prevent electrical shorting between coils 20 and 26 at any point. The solder connections in the embodiment of Figure 1 between delivery wires 12 and 14 and coils 20 and 26, respectively, may similarly be insulated or placed at different longitudinal positions with respect to ends 18 and 24 of insulation 16 in order to avoid or to assist in avoiding short circuits between the solder connections.
The embodiment of Figure 2 illustrates catheter 10 again in simplified side view and is identical in all respects to the embodiment of Figure 1 with the exception that coil 26 has been replaced by a Teflon coated straight platinum wire 32. Although wire 32 is shown in Figure 2 as straight, it must be understood that wire 32 typically has a diameter of 0.025 to 0.25 millimeters and can, in fact, be quite flexible and limp. On the other hand, the stiffness of wire 32 both by its solid geometric cross section, as well as by choice of the platinum-tungsten alloy, can be chosen to have a variety of different stiffnesses as may be desired in order to provide a degree of steerability of tip 28, controlled flexibility or malleability for disposition into the target body cavity.
A third embodiment of catheter 10 is illustrated in the simplified side view of Figure 3. Again, catheter 10 of Figure 3 is identical in all respects to the embodiment of Figure 1 with the exception that coils 20 and 26 are connected to delivery wires 12 and 14 by means of corresponding temporary or detachable junctions 34. Tip 28 is preferably electrolytically detachable by applying a DC
current between delivery wires 12 and 14 and a ground electrode 54, typically applied to an exterior body site and catheter 10 is disposed within the vascular system of a patient as shown in Figure S. The detailed nature of the electrolytic detachment of tip 28 as shown in Figure 3 is described in greater detail in Guglielmi et al., "Endovascular Electrolydcally Detachable Guidewire Tip for the Electroformation of Thrombus in Arteries, Yeins, Aneurysms, Yascular Malformations and Arteriovenous Fistulas," U.S. Patent 5,122,136 (1992), incorporated herein by reference. Alternative means of both electrical and mechanical detachment are contemplated within the invention and are further described in U.S. Patent 5,122,136 ( 1992) and U.S. Patent 5,354,295 ( 1994) each of which are similarly incorporated by reference.
Tip 28 is separated from wires 12 and 14 by electrolytic dissolution of junctions 34. Junctions 34, which are offset from each other to avoid contact with each other, are uninsulated and thus exposed to the blood stream so that they may be electrolytically corroded away at the defined location of the junction and coils 20 and 26 separated from delivery wires 12 and 14. Delivery wires 12 and 14 are thereafter removed, leaving tip 28 embedded in the thrombus thermally formed within the vascular cavity.
Another embodiment is depicted in the side view of Figure 4. Catheter 10 of the embodiment of Figure 4 is substantially identical to the embodiment of Figure 2 with the exception that coils 20 and 32 are coupled to delivery wires 12 and 14, respectively, through temporary junctions 34 of the type described in connection with the embodiment of Figure 3.
The embodiments of Figures 1-4 are employed in the vascular system of a patient as diagrammatically depicted in Figure S. The proximal end of delivery ?179863 wires 12 and 14 are coupled to a signal or power source, generally denoted by reference numeral 36. In the illustrated embodiment of Figure 5, source 36 is diagrammatically shown as symbolically including the double pole, double throw switch 38 for selectively coupling either a DC generator 40 or an AC or RF
S generator 42 to delivery wires 12 and 14. Switch 38 may be of any form, including a solid state switch. Source 36 is a conventional power source and may provide a current for the electrolytic detachment, electrolytic formation of thrombus, and/or thermal formation of thrombi utilizing conventional circuitry or such circuits later devised. As a consequence, further details concerning source 36 will not be discussed.
Catheter 10 is endovascularly disposed within the patient's vascular system using conventional medical techniques. Tip 28 is disposed in a vascular aneuyrsm, arteriovenous malformation or fistula, symbolically denoted by reference numeral 44, and illustrated in the embodiment of Figure 5 as a wide-necked aneurysm 44 having an aneurysm opening or neck approximately 4 millimeters or greater. The apparatus and methodology of the imrention is useful without limitation in aneurysms, malformations and fistulas without limitation, but is shown in connection with a wide-necked aneurysm 44 as being used to particular advantage.
Catheter 10 is disposed through vessel 48 into neck 46 to form a hairbaIl or bird nest of coils comprising tip 28. Tip 28 is substantially proportionally longer then what is suggested in the simplified depictions of Figures 1-4, which, for the sake of simplicity, show tip 28 in a shortened form or at least in a much enlarged scale compared to that of Figure 5. Typically tip 28 is 40 mm to 300 long while delivery wires 12 and 14 with microcatheter 22 may be 1000 to 1500 mm long. Coil tip 28 is thus delivered into aneurysm 44 by use of microcatheter 22 which is then withdrawn from aneurysm 44 into front vessel 48 providing the configuration as illustrated in Figure 5. Therefore, a portion of delivery wires 12 and 14 are disposed in front vessel 48 such that in the embodiment of Figures 3 and 4, junctions 34 are disposed in or near aneurysm 44 or its neck 46. Junction 34 is easily detected through fluoroscopy techniques due to the greater radio-opacity of platinum as opposed to stainless steel A second microcatheter 50 is then disposed into vessel 48 which carries a detachable balloon 52. Balloon 52 is positioned next to neck 46 of aneurysm 48 and temporarily inflated in front vessel 48 to substantially seal across aneurysm neck 46 as depicted in the configuration of Figure 5 or at least to substantial reduce or stop the blood flow past neck 46. Balloon 52 halts the flow of blood allowing the heat that is generated within aneurysm 44, when cofl tip 28 is electrically heated, to be trapped within aneurysm 44. In many, if not most, instances, ff no blood flow arrest were provided in vessel 48, the heat would be carried away by the blood flow and the formation of the thrombus substantially impeded. However, this is not ahways the case, and in some applications the use of balloon 52 is unnecessary. It is anticipated that in other applications, such as narrow necked aneurysms or appropriately shaped vasculated fistulas or malformations, the use of balloon may not be necessary.
An alternating electric current, typically in the range of 20 - 40 volts at 40 milliamps, is then applied to the proximal ends of delivery wires 12 and 14 through switch 38 from source 36. Platinum tip 28 disposed within aneurysm 44 becomes heated and in turn heats the blood within aneurysm 44 to achieve an intra-aneurysmal thrombosis. Various ways of monitoring the infra-aneurysmal temperature can be utilized and incorporated into the design of coil tip 28.
For example, the resistance of the platinum tungsten alloy is a function of its temperature which may be monitored by appropriate conventional resistance detector within source 36. Thermal energy dosages can be determined by temperature and time measurements.
Once thrombosis has been achieved, delivery wires 12 and 14 are then coupled by means of switch 38 to DC generator 40. Typically, direct current of milliamp at 2.5 volts is then applied from DC generator 40 through delivery wires 12 and 14 in parallel, utilizing a body electrode 54 as the opposite DC
electrode.
Junctions 34 thus become electrolytically dissolved so that the platinum tungsten tip 28 now embedded in the clotted aneurysm is detached from catheter 10. Catheter 10 and delivery wires 12 and 14 are then pulled away with balloon 52 deflated and similarly removed.
While the embodiments of Figures 3 and 4 are descn'bed as being used in a method for thrombus formation in Figure 5, any of the embodiments of the imrention and, in particular the embodiments of Figures 1 and 2, may be utlized in applications where endovascular blood heating is needed Figure 6 illustrates one such application used for therapeutic treatment of tumoral cells. In the embodiment of Figure 6, coil tip 28 of catheter 10 is endovascularly disposed within a vessel 56 which leads, for example, into a vasculated tumoral mass 58. Blood flows in vessel 56 in the direction indicated by arrow 60. AC or RF current is then applied to tip 10 providing a controlled degree of heating of blood 60 such that the heated blood is then delivered to tumoral mass 58. Typically, the blood delivered to mass 58 may only be heated by 42 to 47 degrees centigrade to have therapeutic effect.
The temperature elevation is sufficient for many types of cancers to destroy the tumoral cells. It is further expressly contemplated that the tumoral cells may be 2? 7963 tagged or treated to specifically absorb a thermally activated agent that will assist in the destruction of the cell, such as by a thermal cyanin acting in a manner similar to photocyanins. Further, synergistic treatment of tumoral mass 58 is contemplated by combining thermal treatment as descn'bed in Figure 6 with simultaneous or sequential chemotherapy or radiation Figures 7a and b illustrate additional embodiments of catheter 10 utilized in the second technique of the invention. In the embodiment of Figure 7a, a single helical platinum-tungsten coil 62 having a Teflon or other insulating coating thereon is temporarily coupled by means of a detachable junction 64 to a single stainless steel delivery wire 66, which is disposed within an insulated jacket 68.
Again, insulated wire 66 may be disposed within a delivery microcatheter or other catheter assembly as is com~entionally used. The distal end 70 of the insulated platinum-tungsten coil 62 is permanently connected, such as by soldering, to a uninsulated platinum-iridium coil 72. Coil 72 is typically shorter in length than cofl 62.
Cofl 72 serves as an electrode for contact with the blood or body tissue for completion of the circuit to a body electrode 54. Platinum-tungsten coil 62 typically has a substantially higher electrical resistance than either platinum iridium cofl 72 or stainless steel wire 66, so that substantially all the heating is in o0~162.
The embodiment of Figure 7b is identical to that descn'bed in ~ connection with Figure 7a with the exception that temporary detachable junction 64 is replaced by permanent or soldered junction 74.
Catheters 10 of Figures 7a and 7b are employed in a manner as illustrated in connection with Figure 8. Figure 8 is a simplified diagrammatic view which again shows a source 36 having a DC generator 40 and an AC or RF generator 42 coupled through a single pole, double throw switch 76 to delivery wire 66. In the embodiment of Figure 8, AC or RF generator 42 has its opposing electrode coupled to body electrode 54.
Coil tip 28 is comprised in the embodiments of Figures 7a and 7b of coil tip portions b2 and 72 and is disposed by means of microcatheter 22 into vessel 78 and then coupled by means of switch 76 to generator 42. The current is then applied to delivery wire 66 and current flows to coil tip 28 and thence to uninsulated platinum iridium coil 72, which is the only portion of tip 28 in electrical contact with the blood or body fluids. The only portion of current tip 28 which heats to air substantial extent is the platinum tungsten portion, coil 62, because of its relative high electrical resistance.
If catheter 10 is used to occlude an aneurysm, then coil 62 and 72 of tip 28 are then both exposed within the aneurysm and electrolytic~lly detached utilizing the embodiment of Figure 7a. However, if catheter 10 is used to heat the blood, such as for tumoral treatment as shown in Figure 6, then the embodiment of Figure 7b is preferably used.
Many alterations and modifications may be made by those having ordinary skill in the art without departing from the spirit and scope of the imrention.
Therefore, it must be understood that the fllustrated embodiment has been set forth only for the purposes of example and that it should not be taken as limiting the invention as defined by the following claims.
The words used in this specification to descn'be the invention and its various embodiments are to be understood not only in the sense of their commonly defined meanings, but to include by special definition in this specification structure, material or acts beyond the scope of the commonly defined meanings. Thus if an element can be understood in the context of this specification as including more than one meaning, then its use in a claim must be understood as being generic to all possible meanings supported by the specification and by the word iuel~
The definitions of the words or elements of the following claims are, therefore, defined in this specification to include not only the combination of elements which are literally set forth, but all equivalent structure, material or acts for performing substantially the same function in substantially the same way to obtain substantially the same result.
In addition to the equivalents of the claimed elements, obvious substitutions now or later known to one with ordinary skill in the art are defined to be within the scope of the defined elements.
The claims are thus to be understood to include what is specifically illustrated and descn"bed above, what is conceptionally equivalent, what can be obviously substituted and also what essentially incorporates the essential idea of the imrention.
whereby thermal heating of tissue within said vascular system is se=Lectively formed.
The present invention also provides a microcatheter for treating cancer where said microcatheter is disposed within said ~rascular system at a predetermined location in a blood flo~ni to a. tumoral mass, at least one insulated heating coil which is electrically coupled to an insulated delivery wire included within said microcatheter and extending exteriorly to said vascular system, wherein an electrical current is applied through said delivery wire to said heating coil to hat said blood flow within said vascular system at said predetermined location to thermally stress said t:umoral mass downstream;
whereby thermal treatment of said tumoral mass is effected.
In a ~~till further aspect the present invention provides an ~=ndovascular device for use within a vascular system compr_LSing at least= one delivery wire having a first resistance;
and at leash one detachable heating coil having a second resistance coupled to said delivery wire, said first resistance being lr=_ss than said second resistance, wherein 9a said deliver~~ wire and heating coil are both electrically insulated to permit endovascular disposition of said delivery wire and heating coil into said vascular system for the purpose of delivering heat to a fluid within said vascular syst:em at a predetermined location, substantially all of said heat being generated by electrical current flowing within said heating coil rather than within said delivery wire;
whereby endovascular thermal treatment is provided within said ~rascular system.
The present invention also provides a microcatheter for forming <~ thrombus at a predetermined location within a vascular ;system where said microcatheter is disposed within said zTascular system at said predetermined location with at least one insulated heating coil, said insulated heating coil being electrically coupled to an insulated delivery wire included within said microcatheter and extending ext:erior:iy to said vascular system, so that when electrical current is applied through said delivery wire to said heating coil fluid is heated within said vascular system at said predetermined location to thermally form a thrombus thereat, after which said delivery wire is detached from said heating coil, and said microcatheter and delivery wire is withdrawn from said vascular system;
whereby thermal formation of a thrombus within said vascular system is selectively formed.
9b The invention and its various embodiments may be better visualized by turning to the following drawings wherein like elements are referenced by like numerals.
Brief Description of the Drawings Figure 1 is a simplified diagrammatic side view of a catheter tip embodying the present invention.
Figure 2 is a simplified diagrammatic side view of a second embodiment of the invention.
Figure 3 is a simplified diagrammatic side view of a third embodiment of the invention.
Figure 4 is a simplified view of a fourth embodiment of the invention.
Figure 5 is an idealized diagram showing the placement of a catheter utilizing on of the embodiments of the invention within a vascular aneurysm.
Figure 6 is a diagrammatic view of another embodiment of the invention showing utilization for cancei treatment.
Figure 7a is a simplified cross sectional side view of an embodiment for use in a second technique in which the invention may be practiced.
Figure 7b is a simplified side view of a catheter tip illustrated in a second embodiment also used in the second technique of the invention.
Figure 8 is a simplified diagrammatic view which shows a source having a DC
generator and an AC or RF generator coupled through a single pole, double throw switch to the delivery wire.
The invention and its various embodiments may now be understood by turning to the following detailed description.
21~98b3 Detailed Description of the Preferred Embodiments A clot is generated in an aneurysm, arteriovenous malformation or fistula by means of a catheter having an insulated heating coil coupled to an insulated delivery wire. In one embodiment, two delivery wires are coupled to heating coils to provide a closed circuit. The heating coils may be in the form of a double helix or a single helix in combination with a straight heating coil. The heating coils may be permanently connected to the delivery wires or may be electrolytically or mechanically detached therefrom.
Alternatively, a single insulated heating coil may be attached to a single insulated delivery wire with a uninsulated coil attached to the tip of the insulated heating coil. The electrical circuit is then made through the heating coil and non-insulated electrode coil into the vascular system and to a body electrode.
A catheter may also be used for heating blood within the vascular system which is directly flowed into a tumoral mass for the purposes of thermal treatment of cancer.
There are two main ways in which the goal of thermal thrombosis can be achieved in the invention, the first of which is illustrated in connection with Figures 1-6, which use some form of a double wire or closed circuit loop, and the second of which is illustrated in connection with the catheter tips shown in Figures 7a and 7b which uses some form of a single wire or body circuit loop.
Within each of these techniques, the invention may be practiced using a plurality of different embodiments or modifications. Further, the catheter tips of the methodology of the invention can be further be used not only for the promotion of clotting in aneurysms, arteriovenous malformations of fistulas, but also in therapeutic treatment of tumoral cells.
Consider first the first technique of endovascular promotion of the formation of clots as illustrated in Figures 1-5. As shown in Figure 1, a catheter, generally denoted by reference numeral 10, is provided with two insulated stainless steel delivery wires 12 and 14 covered by insulating jackets 16. Additional catheter elements as are now known or later developed in the art may be included in the actual structure of the catheter, which is used. Delivery wires 12 and 14 are shown in isolation of the catheter assembly per se inasmuch as the remaining catheter structure is conventional and largely immaterial to the operation of the invention.
However, it must be clearly understood that the delivery wires 12 and 14 are not necessarily disposed in the vascular system as a pair of associated wires as the simplified diagrammatic side views of Figures 1-4 might suggest. Instead, wires 12 and 14 would be appropriately included within a delivery or guide catheter of conventional design, which is symbolically denoted in Figure 5 by reference numeral 22. Wires 12 and 14 could be coaxial.
Delivery wire 12 terminates at an end 18 of its insulating jacket 16 and is coupled at or near end 18 to a Teflon insulated platinum helix 20. The diameter of platinum helix 20 is typically in the range of 0.1 to 0.5 millimeters and may be comprised of a tight helical platinum wire, which when extended from the end of delivery catheter 22 as shown in Figure 5, forms itself into a helical envelope as depicted by the large helical form in Figures 1-4.
Similarly, stainless steel delivery wire 14 terminates at its end 24 by connection to a Teflon insulated platinum helical coil 26 which, when released, also extends in the embodiment of Figure 1 as a helix. Coils 20 and 26 thus form a pair of helical coils similar in gross geometry to the double helical coil of a DNA
molecule. Helical coils 20 and 26 are coupled together at their distal ends 30, or may be fabricated from a single integral strand of coil, which is then bent or turned at end 30.
The connection between delivery wires 12 and 14 and helical coils 20 and 26, respectively, in the embodiment of Figure 1 is by means of a permanent solder joint, although other types of mechanical and electrical connections are contemplated, some of which are described in the embodiments of Figures 2-4.
Further, in addition to generally forming a helical envelope as shown in Figure 1, platinum coils 20 and 26 may be entirely or substantially limp, or without defined or prebiased form, so that a loose bird nest's configuration is formed by the released coils 20 and 26 as opposed to the tendency to form DNA-like double helix coil structures as shown in the embodiment of Figure 1. In other words, coils 20 and 26 may or may not retain some type of geometric association with each other after being disposed out of the end of catheter 22 depending on the embodiment utilized.
The electrical resistance of platinum or the platinum tungsten alloy from which coils 20 and 26 are fabricated is typically much higher than that of the stainless steel delivery wires which comprise wires 12 and 14. Therefore, it is possible to apply an electrical current to the double helical tip 28, which is comprised of coils 20 and 26, to selectively cause tip 28 to thermally heat with substantially no heat produced in delivery wires 12 and 14, because of the large disparity in the resistance between the two.
The electrical current applied to coil tip 28 through delivery wires 12 and 14 may be a DC current, alternating current, a radiofrequency power signal or any combination of the same. Regardless of the frequency of the electrical current, the current signal may have any envelope desired or be modulated in any way desired including modulation in the form of sin waves, square waves, triangular waves, pulsed, continuous or the like.
Coils 20 and 26 are Teflon coated or provided with another biologically nontoxic insulating material to prevent electrical shorting between coils 20 and 26 at any point. The solder connections in the embodiment of Figure 1 between delivery wires 12 and 14 and coils 20 and 26, respectively, may similarly be insulated or placed at different longitudinal positions with respect to ends 18 and 24 of insulation 16 in order to avoid or to assist in avoiding short circuits between the solder connections.
The embodiment of Figure 2 illustrates catheter 10 again in simplified side view and is identical in all respects to the embodiment of Figure 1 with the exception that coil 26 has been replaced by a Teflon coated straight platinum wire 32. Although wire 32 is shown in Figure 2 as straight, it must be understood that wire 32 typically has a diameter of 0.025 to 0.25 millimeters and can, in fact, be quite flexible and limp. On the other hand, the stiffness of wire 32 both by its solid geometric cross section, as well as by choice of the platinum-tungsten alloy, can be chosen to have a variety of different stiffnesses as may be desired in order to provide a degree of steerability of tip 28, controlled flexibility or malleability for disposition into the target body cavity.
A third embodiment of catheter 10 is illustrated in the simplified side view of Figure 3. Again, catheter 10 of Figure 3 is identical in all respects to the embodiment of Figure 1 with the exception that coils 20 and 26 are connected to delivery wires 12 and 14 by means of corresponding temporary or detachable junctions 34. Tip 28 is preferably electrolytically detachable by applying a DC
current between delivery wires 12 and 14 and a ground electrode 54, typically applied to an exterior body site and catheter 10 is disposed within the vascular system of a patient as shown in Figure S. The detailed nature of the electrolytic detachment of tip 28 as shown in Figure 3 is described in greater detail in Guglielmi et al., "Endovascular Electrolydcally Detachable Guidewire Tip for the Electroformation of Thrombus in Arteries, Yeins, Aneurysms, Yascular Malformations and Arteriovenous Fistulas," U.S. Patent 5,122,136 (1992), incorporated herein by reference. Alternative means of both electrical and mechanical detachment are contemplated within the invention and are further described in U.S. Patent 5,122,136 ( 1992) and U.S. Patent 5,354,295 ( 1994) each of which are similarly incorporated by reference.
Tip 28 is separated from wires 12 and 14 by electrolytic dissolution of junctions 34. Junctions 34, which are offset from each other to avoid contact with each other, are uninsulated and thus exposed to the blood stream so that they may be electrolytically corroded away at the defined location of the junction and coils 20 and 26 separated from delivery wires 12 and 14. Delivery wires 12 and 14 are thereafter removed, leaving tip 28 embedded in the thrombus thermally formed within the vascular cavity.
Another embodiment is depicted in the side view of Figure 4. Catheter 10 of the embodiment of Figure 4 is substantially identical to the embodiment of Figure 2 with the exception that coils 20 and 32 are coupled to delivery wires 12 and 14, respectively, through temporary junctions 34 of the type described in connection with the embodiment of Figure 3.
The embodiments of Figures 1-4 are employed in the vascular system of a patient as diagrammatically depicted in Figure S. The proximal end of delivery ?179863 wires 12 and 14 are coupled to a signal or power source, generally denoted by reference numeral 36. In the illustrated embodiment of Figure 5, source 36 is diagrammatically shown as symbolically including the double pole, double throw switch 38 for selectively coupling either a DC generator 40 or an AC or RF
S generator 42 to delivery wires 12 and 14. Switch 38 may be of any form, including a solid state switch. Source 36 is a conventional power source and may provide a current for the electrolytic detachment, electrolytic formation of thrombus, and/or thermal formation of thrombi utilizing conventional circuitry or such circuits later devised. As a consequence, further details concerning source 36 will not be discussed.
Catheter 10 is endovascularly disposed within the patient's vascular system using conventional medical techniques. Tip 28 is disposed in a vascular aneuyrsm, arteriovenous malformation or fistula, symbolically denoted by reference numeral 44, and illustrated in the embodiment of Figure 5 as a wide-necked aneurysm 44 having an aneurysm opening or neck approximately 4 millimeters or greater. The apparatus and methodology of the imrention is useful without limitation in aneurysms, malformations and fistulas without limitation, but is shown in connection with a wide-necked aneurysm 44 as being used to particular advantage.
Catheter 10 is disposed through vessel 48 into neck 46 to form a hairbaIl or bird nest of coils comprising tip 28. Tip 28 is substantially proportionally longer then what is suggested in the simplified depictions of Figures 1-4, which, for the sake of simplicity, show tip 28 in a shortened form or at least in a much enlarged scale compared to that of Figure 5. Typically tip 28 is 40 mm to 300 long while delivery wires 12 and 14 with microcatheter 22 may be 1000 to 1500 mm long. Coil tip 28 is thus delivered into aneurysm 44 by use of microcatheter 22 which is then withdrawn from aneurysm 44 into front vessel 48 providing the configuration as illustrated in Figure 5. Therefore, a portion of delivery wires 12 and 14 are disposed in front vessel 48 such that in the embodiment of Figures 3 and 4, junctions 34 are disposed in or near aneurysm 44 or its neck 46. Junction 34 is easily detected through fluoroscopy techniques due to the greater radio-opacity of platinum as opposed to stainless steel A second microcatheter 50 is then disposed into vessel 48 which carries a detachable balloon 52. Balloon 52 is positioned next to neck 46 of aneurysm 48 and temporarily inflated in front vessel 48 to substantially seal across aneurysm neck 46 as depicted in the configuration of Figure 5 or at least to substantial reduce or stop the blood flow past neck 46. Balloon 52 halts the flow of blood allowing the heat that is generated within aneurysm 44, when cofl tip 28 is electrically heated, to be trapped within aneurysm 44. In many, if not most, instances, ff no blood flow arrest were provided in vessel 48, the heat would be carried away by the blood flow and the formation of the thrombus substantially impeded. However, this is not ahways the case, and in some applications the use of balloon 52 is unnecessary. It is anticipated that in other applications, such as narrow necked aneurysms or appropriately shaped vasculated fistulas or malformations, the use of balloon may not be necessary.
An alternating electric current, typically in the range of 20 - 40 volts at 40 milliamps, is then applied to the proximal ends of delivery wires 12 and 14 through switch 38 from source 36. Platinum tip 28 disposed within aneurysm 44 becomes heated and in turn heats the blood within aneurysm 44 to achieve an intra-aneurysmal thrombosis. Various ways of monitoring the infra-aneurysmal temperature can be utilized and incorporated into the design of coil tip 28.
For example, the resistance of the platinum tungsten alloy is a function of its temperature which may be monitored by appropriate conventional resistance detector within source 36. Thermal energy dosages can be determined by temperature and time measurements.
Once thrombosis has been achieved, delivery wires 12 and 14 are then coupled by means of switch 38 to DC generator 40. Typically, direct current of milliamp at 2.5 volts is then applied from DC generator 40 through delivery wires 12 and 14 in parallel, utilizing a body electrode 54 as the opposite DC
electrode.
Junctions 34 thus become electrolytically dissolved so that the platinum tungsten tip 28 now embedded in the clotted aneurysm is detached from catheter 10. Catheter 10 and delivery wires 12 and 14 are then pulled away with balloon 52 deflated and similarly removed.
While the embodiments of Figures 3 and 4 are descn'bed as being used in a method for thrombus formation in Figure 5, any of the embodiments of the imrention and, in particular the embodiments of Figures 1 and 2, may be utlized in applications where endovascular blood heating is needed Figure 6 illustrates one such application used for therapeutic treatment of tumoral cells. In the embodiment of Figure 6, coil tip 28 of catheter 10 is endovascularly disposed within a vessel 56 which leads, for example, into a vasculated tumoral mass 58. Blood flows in vessel 56 in the direction indicated by arrow 60. AC or RF current is then applied to tip 10 providing a controlled degree of heating of blood 60 such that the heated blood is then delivered to tumoral mass 58. Typically, the blood delivered to mass 58 may only be heated by 42 to 47 degrees centigrade to have therapeutic effect.
The temperature elevation is sufficient for many types of cancers to destroy the tumoral cells. It is further expressly contemplated that the tumoral cells may be 2? 7963 tagged or treated to specifically absorb a thermally activated agent that will assist in the destruction of the cell, such as by a thermal cyanin acting in a manner similar to photocyanins. Further, synergistic treatment of tumoral mass 58 is contemplated by combining thermal treatment as descn'bed in Figure 6 with simultaneous or sequential chemotherapy or radiation Figures 7a and b illustrate additional embodiments of catheter 10 utilized in the second technique of the invention. In the embodiment of Figure 7a, a single helical platinum-tungsten coil 62 having a Teflon or other insulating coating thereon is temporarily coupled by means of a detachable junction 64 to a single stainless steel delivery wire 66, which is disposed within an insulated jacket 68.
Again, insulated wire 66 may be disposed within a delivery microcatheter or other catheter assembly as is com~entionally used. The distal end 70 of the insulated platinum-tungsten coil 62 is permanently connected, such as by soldering, to a uninsulated platinum-iridium coil 72. Coil 72 is typically shorter in length than cofl 62.
Cofl 72 serves as an electrode for contact with the blood or body tissue for completion of the circuit to a body electrode 54. Platinum-tungsten coil 62 typically has a substantially higher electrical resistance than either platinum iridium cofl 72 or stainless steel wire 66, so that substantially all the heating is in o0~162.
The embodiment of Figure 7b is identical to that descn'bed in ~ connection with Figure 7a with the exception that temporary detachable junction 64 is replaced by permanent or soldered junction 74.
Catheters 10 of Figures 7a and 7b are employed in a manner as illustrated in connection with Figure 8. Figure 8 is a simplified diagrammatic view which again shows a source 36 having a DC generator 40 and an AC or RF generator 42 coupled through a single pole, double throw switch 76 to delivery wire 66. In the embodiment of Figure 8, AC or RF generator 42 has its opposing electrode coupled to body electrode 54.
Coil tip 28 is comprised in the embodiments of Figures 7a and 7b of coil tip portions b2 and 72 and is disposed by means of microcatheter 22 into vessel 78 and then coupled by means of switch 76 to generator 42. The current is then applied to delivery wire 66 and current flows to coil tip 28 and thence to uninsulated platinum iridium coil 72, which is the only portion of tip 28 in electrical contact with the blood or body fluids. The only portion of current tip 28 which heats to air substantial extent is the platinum tungsten portion, coil 62, because of its relative high electrical resistance.
If catheter 10 is used to occlude an aneurysm, then coil 62 and 72 of tip 28 are then both exposed within the aneurysm and electrolytic~lly detached utilizing the embodiment of Figure 7a. However, if catheter 10 is used to heat the blood, such as for tumoral treatment as shown in Figure 6, then the embodiment of Figure 7b is preferably used.
Many alterations and modifications may be made by those having ordinary skill in the art without departing from the spirit and scope of the imrention.
Therefore, it must be understood that the fllustrated embodiment has been set forth only for the purposes of example and that it should not be taken as limiting the invention as defined by the following claims.
The words used in this specification to descn'be the invention and its various embodiments are to be understood not only in the sense of their commonly defined meanings, but to include by special definition in this specification structure, material or acts beyond the scope of the commonly defined meanings. Thus if an element can be understood in the context of this specification as including more than one meaning, then its use in a claim must be understood as being generic to all possible meanings supported by the specification and by the word iuel~
The definitions of the words or elements of the following claims are, therefore, defined in this specification to include not only the combination of elements which are literally set forth, but all equivalent structure, material or acts for performing substantially the same function in substantially the same way to obtain substantially the same result.
In addition to the equivalents of the claimed elements, obvious substitutions now or later known to one with ordinary skill in the art are defined to be within the scope of the defined elements.
The claims are thus to be understood to include what is specifically illustrated and descn"bed above, what is conceptionally equivalent, what can be obviously substituted and also what essentially incorporates the essential idea of the imrention.
Claims (36)
1. An improvement in an endovascular device for use within a vascular system comprising:
at least one elongate, flexible, fully insulated and substantially unsupported delivery wire having a first resistance; and at least one elongate, flexible, fully insulated, substantially unsupported, and longitudinally resilient heating coil having a second resistance coupled to said delivery wire, said first resistance being less than said second resistance, wherein said delivery wire and heating coil are both electrically insulated to permit endovascular disposition of said delivery wire and heating coil into said vascular system to deliver heat to blood within said vascular system at a predetermined location, substantially all of said heat being generated by electrical current flowing within said heating coil rather than within said delivery wire;
whereby endovascular thermal treatment is provided within said vascular system.
at least one elongate, flexible, fully insulated and substantially unsupported delivery wire having a first resistance; and at least one elongate, flexible, fully insulated, substantially unsupported, and longitudinally resilient heating coil having a second resistance coupled to said delivery wire, said first resistance being less than said second resistance, wherein said delivery wire and heating coil are both electrically insulated to permit endovascular disposition of said delivery wire and heating coil into said vascular system to deliver heat to blood within said vascular system at a predetermined location, substantially all of said heat being generated by electrical current flowing within said heating coil rather than within said delivery wire;
whereby endovascular thermal treatment is provided within said vascular system.
2. The improvement of claim 1 wherein said delivery wire and heating coil are permanently coupled to each other.
3. The improvement of claim 1 further comprising a body electrode adapted to be in contact with a body having said vascular system and therefore in electrical circuit with said vascular system, and wherein said heating coil has a proximal and distal end, said proximal end being coupled to said delivery wire and further comprising a uninsulated coil coupled to said distal end of said heating coil, said uninsulated coil having an electrical resistance, said electrical resistance of said uninsulated coil being less than said heating coil so that substantially all of said heat generated by said current is generated within said heating coil, said uninsulated coil serving as an endovascular electrode to provide completion of circuit through said delivery wire, and heating coil to said body electrode.
4. The improvement of claim 3 wherein said delivery wire and heating coil are permanently coupled to each other.
5. The improvement of claim 1 further comprising a current source coupled to said delivery wire for controllably delivering said electrical current thereto.
6. An improvement in an endovascular device for use within a vascular system comprising:
at least one delivery wire having a first resistance;
at least one heating coil having a second resistance coupled to said delivery wire, said first resistance being less than said second resistance, wherein said delivery wire and heating coil are both electrically insulated to permit endovascular disposition of said delivery wire and heating coil into said vascular system to deliver heat to a fluid within said vascular system at a predetermined location, substantially all of said heat being generated by electrical current flowing within said heating coil rather than within said delivery wire; and at least two delivery wires and at least two heating coils each having a proximal and distal end, said proximal end of each of said heating coils being coupled to corresponding ones of said two delivery wires, said distal end of said two heating coils being coupled together to provide a continuous circuit through a first one of said two deliverer wires to a first one of said two heating coils, to a second. one of said two heating coils, and to a second one of sail. two delivery wires;
whereby endovascular thermal treatment is provided within said vascular system.
at least one delivery wire having a first resistance;
at least one heating coil having a second resistance coupled to said delivery wire, said first resistance being less than said second resistance, wherein said delivery wire and heating coil are both electrically insulated to permit endovascular disposition of said delivery wire and heating coil into said vascular system to deliver heat to a fluid within said vascular system at a predetermined location, substantially all of said heat being generated by electrical current flowing within said heating coil rather than within said delivery wire; and at least two delivery wires and at least two heating coils each having a proximal and distal end, said proximal end of each of said heating coils being coupled to corresponding ones of said two delivery wires, said distal end of said two heating coils being coupled together to provide a continuous circuit through a first one of said two deliverer wires to a first one of said two heating coils, to a second. one of said two heating coils, and to a second one of sail. two delivery wires;
whereby endovascular thermal treatment is provided within said vascular system.
7. The improvement of claim 6 wherein aid two heating coils are each helical and together from a double helical tip.
8. The improvement of claim 7 wherein said delivery wire and heating coil are permanently coupled to each other.
9. The improvement of claim 6 wherein one of said two delivery wires is helical and the other one of said two delivery wires is non-helical.
10. A microcatheter for selectively heating tissue at a predetermined location within a vascular system where said microcatheter is disposed within said vascular system at said predetermined location, said microcatheter comprising air least one insulated heating coil disposed by said microcatheter at said predetermined location, said insulated heating coil being electrically coupled to an insulated delivery wire included within said microcatheter and extending exteriorly to said vascular system, wherein electrical current is applied through said delivery wire to said heating coil t:o heat blood within said vascular system at said predetermined location to thermally heat tissue in contact with said blood; and after which said microcatheter and delivery wire is withdrawn from said vascular system;
whereby thermal heating of tissue within said vascular system is selectively formed.
whereby thermal heating of tissue within said vascular system is selectively formed.
11. The microcatheter of claim 10 where at least two insulated heating coils connected together in an electrical circuit are disposed in said vascular system.
12. The microcatheter of claim 10 wherein said heating coil is characterized such that application of said current to said delivery wire and heating coil resistively generates heat substantially only within said heating coil.
13. the microcatheter of claim 10 further comprising a body electrode, and where said heating coil comprises an uninsulated coil tip electrode in electrical contact with said blood in said vascular system for completing an electrical circuit through said delivery wire, heating coil and coil tip electrode to said body electrode in electrical communication with said vascular system.
14. A microcatheter for treating cancer where said microcatheter is disposed within said vascular system at a predetermined location in a blood flow to a tumoral mass, at least one insulated heating coil which is electrically coupled to an insulated delivery wire included within said microcatheter and extending exteriorly to said vascular system, wherein an electrical current is applied through said delivery wire to said heating coil to hat said blood flow within said vascular system at said predetermined location to thermally stress said tumoral mass downstream;
whereby thermal treatment of said tumoral mass is effected.
whereby thermal treatment of said tumoral mass is effected.
15. The microcatheter of claim 14 where at least two insulated heating coils are included and connected together in an electrical circuit in said vascular system.
16. The microcatheter of claim 14 where application of said currently to said delivery wire and heating coil resistively generates heat substantially only within said heating coil.
17. The microcatheter of claim 14 further comprising an uninsulated coil tip, and a body electrode, and where current is applied through said heating coil to said uninsulated coil tip in electrical contact with said blood in said vascular system to complete an electrical circuit through said delivery wire, heating coil and uninsulated coil tip to said body electrode in electrical communication with said vascular system.
18. An endovascular device for use within a vascular system comprising:
at least one delivery wire having a first resistance;
and at least one detachable heating coil having a second resistance coupled to said delivery wire, said first resistance being less than said second resistance, wherein said delivery wire and heating coil are both electrically insulated to permit endovascular disposition of said delivery wire and heating coil into said vascular system for the purpose of delivering heat to a fluid within said vascular system at a predetermined location, substantially all of said heat being generated by electrical current flowing within said heating coil rather than within said delivery wire;
whereby endovascular thermal treatment is provided within said vascular system.
c
at least one delivery wire having a first resistance;
and at least one detachable heating coil having a second resistance coupled to said delivery wire, said first resistance being less than said second resistance, wherein said delivery wire and heating coil are both electrically insulated to permit endovascular disposition of said delivery wire and heating coil into said vascular system for the purpose of delivering heat to a fluid within said vascular system at a predetermined location, substantially all of said heat being generated by electrical current flowing within said heating coil rather than within said delivery wire;
whereby endovascular thermal treatment is provided within said vascular system.
c
19. The endovascular device of claim 18 wherein said delivery wire and heating coil are temporarily coupled to each other and can be selectively detached while disposed in said vascular system
20. The endovascular device of claim 19 wherein said delivery wire and heating coil are electrolytically detachable from each other.
21. The endovascular device of claim 19 wherein said delivery wire and heating coil are mechanically detachable from each other.
22. The endovascular device of claim 18 further comprising at least two delivery wires and at least two heating coils each having a proximal and distal end, said proximal end of each of said heating coils being coupled to corresponding ones of said two delivery wires, said distal end of said two heating coils being coupled together to provide a continuous circuit through a first one of said two delivery wires to a first one of said two heating coils, to a second one of said two heating coils, and to a second one of said two delivery wires.
23. The endovascular device of claim 21 wherein said two heating coils are each helical and together form a double helical tip.
24. The endovascular device of claim 23 wherein said two delivery coils are temporarily coupled to each other, each one of said two delivery wires being coupled to one of said two heating coils, and therein said temporarily coupled delivery wire and heating coil can be selectively detached from each other while within said vascular system.
25. The endovascular device of claim 23 where each one of said two delivery wires are coupled to one of said two heating coils, wherein each one of said two delivery wires and said two heating coils are electrolytically detachable from each other.
26. The endovascular device of claim 22 wherein one of said two delivery wires is helical and the other one of said two delivery wires is non-helical.
27. The endovascular device of claim 24 where each of said two delivery wires are coupled to one of said two heating coils, wherein each one of said two delivery wires and said two heating coils are temporarily coupled to each other and can be selectively detached from each other.
28. The endovascular device of claim 26 where each one of said two delivery wires are coupled to one of said two heating coils, and wherein each one of said two delivery wires and said two heating coil are electrolytically detachable from each other.
29. The endovascular device of claim 18 further comprising a body electrode adapted to be in electrical circuit with said vascular system and with said delivery wire, wherein said heating coil has a proximal and distal end, said proximal end being coupled to said delivery wire and further comprising a uninsulated coil coupled to said distal end of said heating coil, said uninsulated coil having an electrical resistance, said electrical resistance of said uninsulated coil being less than said heating coil so that substantially all of said heat generated by said current is generated within said heating coil, said uninsulated coil serving as an endovascular electrode to provide completion of circuit through said delivery wire and heating coil.
30. The endovascular device of claim 29 wherein said delivery wire and heating coil are temporarily coupled to each other anal can be selectively detached within said vascular system.
31. The endovascular device of claim 29 wherein said delivery wire and heating coil are electrolytically detachable from each other.
32. The endovascular device of claim 18 further comprising a current source to said delivery wire for controllably delivering said electrical current thereto.
33. A microcatheter for forming a thrombus at a predetermined location within a vascular system where said microcatheter is disposed within said vascular system at said predetermined location with at least one insulated heating coil, said insulated heating coil being electrically coupled to an insulated delivery wire included within said microcatheter and extending exteriorly to said vascular system, so that when electrical current is applied through said delivery wire to said heating coil fluid is heated within said vascular system at said predetermined location to thermally form a thrombus thereat, after which said deliverer wire is detached from said heating coil, and said microcatheter and delivery wire is withdrawn from said vascular system;
whereby thermal formation of a thrombus within said vascular system is selectively formed.
whereby thermal formation of a thrombus within said vascular system is selectively formed.
34. The microcatheter of claim 33 where at least two insulated heating coils are connected together in an electrical circuit.
35. The microcatheter of claim 33 where application of said current to said delivery wire and heating coil resistively generates heat substantially only within said heating coil.
36. The microcatheter of claim 33 further comprising an uninsulated coil tip electrode and a body electrode, and where application of current through said heating coil to said uninsulated coil tip electrode in electrical contact with said fluid in said vascular system completes an electrical circuit through said delivery wire, heating coil and coil tip electrode to said body electrode in electrical communication with said vascular system.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/497,294 US5851206A (en) | 1990-03-13 | 1995-06-30 | Method and apparatus for endovascular thermal thrombosis and thermal cancer treatment |
US08/497,294 | 1995-06-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2179863A1 CA2179863A1 (en) | 1996-12-31 |
CA2179863C true CA2179863C (en) | 2001-09-11 |
Family
ID=23976267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002179863A Expired - Fee Related CA2179863C (en) | 1995-06-30 | 1996-06-25 | Method and apparatus for endovascular thermal thrombosis and thermal cancer treatment |
Country Status (12)
Country | Link |
---|---|
US (2) | US5851206A (en) |
EP (1) | EP0750886B1 (en) |
JP (1) | JP3131386B2 (en) |
KR (1) | KR100437847B1 (en) |
AT (1) | ATE236583T1 (en) |
AU (1) | AU723902B2 (en) |
CA (1) | CA2179863C (en) |
DE (1) | DE69627243T2 (en) |
DK (1) | DK0750886T3 (en) |
ES (1) | ES2196123T3 (en) |
NO (1) | NO321938B1 (en) |
TW (1) | TW396029B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE42625E1 (en) | 1990-03-13 | 2011-08-16 | The Regents Of The University Of California | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
USRE42662E1 (en) | 1990-03-13 | 2011-08-30 | The Regents Of The University Of California | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
USRE42756E1 (en) | 1990-03-13 | 2011-09-27 | The Regents Of The University Of California | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
Families Citing this family (196)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5350397A (en) | 1992-11-13 | 1994-09-27 | Target Therapeutics, Inc. | Axially detachable embolic coil assembly |
US5800453A (en) * | 1993-04-19 | 1998-09-01 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking hooks and slots |
US5690671A (en) * | 1994-12-13 | 1997-11-25 | Micro Interventional Systems, Inc. | Embolic elements and methods and apparatus for their delivery |
US5814062A (en) | 1994-12-22 | 1998-09-29 | Target Therapeutics, Inc. | Implant delivery assembly with expandable coupling/decoupling mechanism |
US6984240B1 (en) | 1996-10-25 | 2006-01-10 | Target Therapeutics, Inc. | Detachable multidiameter vasoocclusive coil |
US6156061A (en) | 1997-08-29 | 2000-12-05 | Target Therapeutics, Inc. | Fast-detaching electrically insulated implant |
US5984929A (en) | 1997-08-29 | 1999-11-16 | Target Therapeutics, Inc. | Fast detaching electronically isolated implant |
JP4130234B2 (en) * | 1997-10-30 | 2008-08-06 | 株式会社カネカメディックス | Medical device for placement of in-vivo indwelling members |
US6136015A (en) * | 1998-08-25 | 2000-10-24 | Micrus Corporation | Vasoocclusive coil |
US6280441B1 (en) * | 1997-12-15 | 2001-08-28 | Sherwood Services Ag | Apparatus and method for RF lesioning |
US6475227B2 (en) | 1997-12-24 | 2002-11-05 | Scimed Life Systems, Inc. | Vaso-occlusion apparatus having a mechanically expandable detachment joint and a method for using the apparatus |
US6346091B1 (en) * | 1998-02-13 | 2002-02-12 | Stephen C. Jacobsen | Detachable coil for aneurysm therapy |
US5935145A (en) | 1998-02-13 | 1999-08-10 | Target Therapeutics, Inc. | Vaso-occlusive device with attached polymeric materials |
US6022369A (en) * | 1998-02-13 | 2000-02-08 | Precision Vascular Systems, Inc. | Wire device with detachable end |
US5941888A (en) | 1998-02-18 | 1999-08-24 | Target Therapeutics, Inc. | Vaso-occlusive member assembly with multiple detaching points |
US6077260A (en) * | 1998-02-19 | 2000-06-20 | Target Therapeutics, Inc. | Assembly containing an electrolytically severable joint for endovascular embolic devices |
WO1999062432A1 (en) | 1998-06-04 | 1999-12-09 | New York University | Endovascular thin film devices and methods for treating and preventing stroke |
US6478773B1 (en) * | 1998-12-21 | 2002-11-12 | Micrus Corporation | Apparatus for deployment of micro-coil using a catheter |
FR2785172B1 (en) * | 1998-11-02 | 2000-12-29 | Assist Publ Hopitaux De Paris | BIOCOMPATIBLE METAL SPIRE AND DEVICES FOR LAYING ADJUSTABLE LENGTH ELECTROSECABLE VASCULAR OCCLUSION |
US6835185B2 (en) | 1998-12-21 | 2004-12-28 | Micrus Corporation | Intravascular device deployment mechanism incorporating mechanical detachment |
US7412285B2 (en) * | 1999-04-09 | 2008-08-12 | Oncostim, Inc. | Method and device for treating cancer with electrical therapy in conjunction with chemotherapeutic agents and radiation therapy |
EP1992308B1 (en) | 1999-06-02 | 2015-10-28 | Microtransform, Inc. | Intracorporeal occlusive device |
US8048104B2 (en) | 2000-10-30 | 2011-11-01 | Dendron Gmbh | Device for the implantation of occlusion spirals |
JP2001161838A (en) * | 1999-12-07 | 2001-06-19 | Radiomed Corp | Wire-like radiation source member for cancer treatment and feeding device of the same |
US6397850B1 (en) * | 2000-02-09 | 2002-06-04 | Scimed Life Systems Inc | Dual-mode apparatus and method for detection of embolic device detachment |
US8024048B2 (en) * | 2000-03-13 | 2011-09-20 | Ionix Medical Inc. | Method and device for treating cancer with electrical therapy in conjunction with chemotherapeutic agents and radiation therapy |
US7742811B2 (en) * | 2000-03-13 | 2010-06-22 | Onco Stim | Implantable device and method for the electrical treatment of cancer |
US6650943B1 (en) | 2000-04-07 | 2003-11-18 | Advanced Bionics Corporation | Fully implantable neurostimulator for cavernous nerve stimulation as a therapy for erectile dysfunction and other sexual dysfunction |
US6375654B1 (en) * | 2000-05-19 | 2002-04-23 | Cardiofocus, Inc. | Catheter system with working portion radially expandable upon rotation |
US6855154B2 (en) | 2000-08-11 | 2005-02-15 | University Of Louisville Research Foundation, Inc. | Endovascular aneurysm treatment device and method |
US6676657B2 (en) | 2000-12-07 | 2004-01-13 | The United States Of America As Represented By The Department Of Health And Human Services | Endoluminal radiofrequency cauterization system |
US6529775B2 (en) | 2001-01-16 | 2003-03-04 | Alsius Corporation | System and method employing indwelling RF catheter for systemic patient warming by application of dielectric heating |
US6641603B2 (en) | 2001-04-13 | 2003-11-04 | Alsius Corporation | Heat exchange catheter having helically wound reinforcement |
US6709448B2 (en) | 2001-04-13 | 2004-03-23 | Alsius Corporation | Open core heat exchange catheter, system and method |
US6901296B1 (en) | 2001-05-25 | 2005-05-31 | Advanced Bionics Corporation | Methods and systems for direct electrical current stimulation as a therapy for cancer and other neoplastic diseases |
US6885895B1 (en) * | 2001-04-26 | 2005-04-26 | Advanced Bionics Corporation | Methods and systems for electrical and/or drug stimulation as a therapy for erectile dysfunction |
US6901294B1 (en) | 2001-05-25 | 2005-05-31 | Advanced Bionics Corporation | Methods and systems for direct electrical current stimulation as a therapy for prostatic hypertrophy |
US20050240229A1 (en) * | 2001-04-26 | 2005-10-27 | Whitehurst Tood K | Methods and systems for stimulation as a therapy for erectile dysfunction |
US7219799B2 (en) * | 2002-12-31 | 2007-05-22 | Possis Medical, Inc. | Packaging system with oxygen sensor |
US6953473B2 (en) * | 2001-12-20 | 2005-10-11 | Boston Scientific Scimed, Inc. | Detachable device with electrically responsive element |
US8774922B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods |
US20070135875A1 (en) | 2002-04-08 | 2007-06-14 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US20070129761A1 (en) | 2002-04-08 | 2007-06-07 | Ardian, Inc. | Methods for treating heart arrhythmia |
US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US9308043B2 (en) | 2002-04-08 | 2016-04-12 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monopolar renal neuromodulation |
US8145316B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US20140018880A1 (en) | 2002-04-08 | 2014-01-16 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monopolar renal neuromodulation |
US8145317B2 (en) * | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods for renal neuromodulation |
US9636174B2 (en) | 2002-04-08 | 2017-05-02 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
US7853333B2 (en) | 2002-04-08 | 2010-12-14 | Ardian, Inc. | Methods and apparatus for multi-vessel renal neuromodulation |
US7617005B2 (en) | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US8150519B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
US9308044B2 (en) | 2002-04-08 | 2016-04-12 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
US8131371B2 (en) * | 2002-04-08 | 2012-03-06 | Ardian, Inc. | Methods and apparatus for monopolar renal neuromodulation |
US7162303B2 (en) | 2002-04-08 | 2007-01-09 | Ardian, Inc. | Renal nerve stimulation method and apparatus for treatment of patients |
US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US7620451B2 (en) | 2005-12-29 | 2009-11-17 | Ardian, Inc. | Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach |
US20080213331A1 (en) | 2002-04-08 | 2008-09-04 | Ardian, Inc. | Methods and devices for renal nerve blocking |
US8774913B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravasculary-induced neuromodulation |
US6978174B2 (en) | 2002-04-08 | 2005-12-20 | Ardian, Inc. | Methods and devices for renal nerve blocking |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US8150520B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods for catheter-based renal denervation |
US8235990B2 (en) | 2002-06-14 | 2012-08-07 | Ncontact Surgical, Inc. | Vacuum coagulation probes |
US7572257B2 (en) * | 2002-06-14 | 2009-08-11 | Ncontact Surgical, Inc. | Vacuum coagulation and dissection probes |
US9439714B2 (en) | 2003-04-29 | 2016-09-13 | Atricure, Inc. | Vacuum coagulation probes |
US7063698B2 (en) | 2002-06-14 | 2006-06-20 | Ncontact Surgical, Inc. | Vacuum coagulation probes |
US6893442B2 (en) | 2002-06-14 | 2005-05-17 | Ablatrics, Inc. | Vacuum coagulation probe for atrial fibrillation treatment |
US20040082859A1 (en) | 2002-07-01 | 2004-04-29 | Alan Schaer | Method and apparatus employing ultrasound energy to treat body sphincters |
DE10233085B4 (en) | 2002-07-19 | 2014-02-20 | Dendron Gmbh | Stent with guide wire |
US8425549B2 (en) | 2002-07-23 | 2013-04-23 | Reverse Medical Corporation | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
US7744583B2 (en) * | 2003-02-03 | 2010-06-29 | Boston Scientific Scimed | Systems and methods of de-endothelialization |
US6979330B2 (en) * | 2003-03-13 | 2005-12-27 | Boston Scientific Scimed, Inc. | System for indirectly ablating tissue using implanted electrode devices |
ES2346059T3 (en) | 2003-03-26 | 2010-10-08 | Biosensors International Group Ltd. | IMPLANT SUPPLY CATHETER WITH ELECTROLYTICALLY EROSIONABLE JOINTS. |
US7771463B2 (en) | 2003-03-26 | 2010-08-10 | Ton Dai T | Twist-down implant delivery technologies |
US8016869B2 (en) | 2003-03-26 | 2011-09-13 | Biosensors International Group, Ltd. | Guidewire-less stent delivery methods |
BRPI0410324A (en) | 2003-05-15 | 2006-05-23 | Biomerix Corp | implantable device, elastomeric matrix production lyophilization processes having a cross-linked structure, polymerization for cross-linked elastomeric matrix preparation and cross-linked composite elastomeric implant preparation, and method for treating an orthopedic disorder |
US7569626B2 (en) * | 2003-06-05 | 2009-08-04 | Dfine, Inc. | Polymer composites for biomedical applications and methods of making |
US8043321B2 (en) * | 2003-07-24 | 2011-10-25 | Boston Scientific Scimed, Inc. | Embolic coil |
WO2005042081A1 (en) * | 2003-10-28 | 2005-05-12 | Peacock James C Iii | Embolic filter device and related systems and methods |
US7763077B2 (en) | 2003-12-24 | 2010-07-27 | Biomerix Corporation | Repair of spinal annular defects and annulo-nucleoplasty regeneration |
DE102004003265A1 (en) * | 2004-01-21 | 2005-08-11 | Dendron Gmbh | Device for the implantation of electrically isolated occlusion coils |
JP2007519498A (en) * | 2004-01-30 | 2007-07-19 | エヌエムティー メディカル, インコーポレイティッド | Devices, systems, and methods for closure of cardiac openings |
US7651521B2 (en) | 2004-03-02 | 2010-01-26 | Cardiomind, Inc. | Corewire actuated delivery system with fixed distal stent-carrying extension |
US7775087B2 (en) * | 2004-03-16 | 2010-08-17 | Northwestern University | Microchannel forming method and nanotipped dispensing device having a microchannel |
US7720549B2 (en) * | 2004-04-06 | 2010-05-18 | Oncostim, Inc. | Partially implantable system for the electrical treatment of abnormal tissue growth |
AU2011204895B2 (en) * | 2004-08-25 | 2013-09-19 | Microvention, Inc. | Thermal detachment system for implantable devices |
US7879064B2 (en) | 2004-09-22 | 2011-02-01 | Micro Therapeutics, Inc. | Medical implant |
ATE448737T1 (en) | 2004-09-22 | 2009-12-15 | Dendron Gmbh | DEVICE FOR IMPLANTING MICROWL COILS |
US20060074409A1 (en) * | 2004-10-05 | 2006-04-06 | Scimed Life Systems, Inc. | Detachable shaft medical retrieval device and related methods of use |
US7937143B2 (en) | 2004-11-02 | 2011-05-03 | Ardian, Inc. | Methods and apparatus for inducing controlled renal neuromodulation |
USRE47376E1 (en) * | 2005-04-01 | 2019-05-07 | Nexgen Medical Systems, Incorporated | Thrombus removal system and process |
US7955345B2 (en) * | 2005-04-01 | 2011-06-07 | Nexgen Medical Systems, Inc. | Thrombus removal system and process |
US7955344B2 (en) * | 2005-04-01 | 2011-06-07 | Nexgen Medical Systems, Inc. | Thrombus removal system and process |
US8603122B2 (en) * | 2005-04-01 | 2013-12-10 | Nexgen Medical Systems, Incorporated | Thrombus removal system and process |
US7962208B2 (en) | 2005-04-25 | 2011-06-14 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
DE102005019782A1 (en) * | 2005-04-28 | 2006-11-09 | Dendron Gmbh | Device for implantation of occlusion coils with internal securing means |
WO2007014063A2 (en) * | 2005-07-21 | 2007-02-01 | Vnus Medical Technologies, Inc. | Systems and methods for treating a hollow anatomical structure |
US20070073334A1 (en) * | 2005-09-29 | 2007-03-29 | Kamal Ramzipoor | Combined electrolytic and mechanical separation background |
US20070100414A1 (en) | 2005-11-02 | 2007-05-03 | Cardiomind, Inc. | Indirect-release electrolytic implant delivery systems |
US8377056B2 (en) * | 2005-12-29 | 2013-02-19 | Boston Scientific Scimed, Inc. | Method of treating tissue with radio frequency vascular electrode array |
US7699884B2 (en) | 2006-03-22 | 2010-04-20 | Cardiomind, Inc. | Method of stenting with minimal diameter guided delivery systems |
US8777979B2 (en) | 2006-04-17 | 2014-07-15 | Covidien Lp | System and method for mechanically positioning intravascular implants |
CA2649702C (en) | 2006-04-17 | 2014-12-09 | Microtherapeutics, Inc. | System and method for mechanically positioning intravascular implants |
GB0700553D0 (en) * | 2007-01-11 | 2007-02-21 | Emcision Ltd | Vessel sealing device |
US7819865B2 (en) | 2006-09-20 | 2010-10-26 | Covidien Ag | Electrosurgical radio frequency energy transmission medium |
US20080269774A1 (en) | 2006-10-26 | 2008-10-30 | Chestnut Medical Technologies, Inc. | Intracorporeal Grasping Device |
KR20100015520A (en) | 2007-03-13 | 2010-02-12 | 마이크로 테라퓨틱스 인코포레이티드 | An implant including a coil and a stretch-resistant member |
KR20100015521A (en) | 2007-03-13 | 2010-02-12 | 마이크로 테라퓨틱스 인코포레이티드 | An implant, a mandrel, and a method of forming an implant |
EP2142070B1 (en) * | 2007-04-27 | 2021-01-06 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter |
CA2691969A1 (en) | 2007-05-18 | 2008-11-27 | Boston Scientific Scimed, Inc. | Medical implant detachment systems |
US8202269B2 (en) * | 2007-05-25 | 2012-06-19 | The Regents Of The Universtiy Of Michigan | Electrical cautery device |
AU2008279505A1 (en) * | 2007-07-20 | 2009-01-29 | Stryker Corporation | Power supply using time varying signal for electrolytically detaching implantable device |
US20160220265A1 (en) * | 2007-10-12 | 2016-08-04 | NexGen Medical Systems Incorporated, | Thrombus removal system and process |
US11337714B2 (en) | 2007-10-17 | 2022-05-24 | Covidien Lp | Restoring blood flow and clot removal during acute ischemic stroke |
US8088140B2 (en) | 2008-05-19 | 2012-01-03 | Mindframe, Inc. | Blood flow restorative and embolus removal methods |
JP5366974B2 (en) | 2007-12-21 | 2013-12-11 | マイクロベンション インコーポレイテッド | System and method for determining the position of a separation zone of a separable implant |
EP2234562B1 (en) | 2007-12-21 | 2019-02-27 | MicroVention, Inc. | A system and method of detecting implant detachment |
KR101819554B1 (en) | 2008-02-22 | 2018-01-17 | 마이크로 테라퓨틱스 인코포레이티드 | Methods and apparatus for flow restoration |
US8457738B2 (en) | 2008-06-19 | 2013-06-04 | Cardiac Pacemakers, Inc. | Pacing catheter for access to multiple vessels |
US9409012B2 (en) | 2008-06-19 | 2016-08-09 | Cardiac Pacemakers, Inc. | Pacemaker integrated with vascular intervention catheter |
US9037235B2 (en) | 2008-06-19 | 2015-05-19 | Cardiac Pacemakers, Inc. | Pacing catheter with expandable distal end |
JP5282142B2 (en) * | 2008-06-19 | 2013-09-04 | カーディアック ペースメイカーズ, インコーポレイテッド | Pacing catheter with expandable distal end |
US8244352B2 (en) | 2008-06-19 | 2012-08-14 | Cardiac Pacemakers, Inc. | Pacing catheter releasing conductive liquid |
US8639357B2 (en) | 2008-06-19 | 2014-01-28 | Cardiac Pacemakers, Inc. | Pacing catheter with stent electrode |
WO2010019481A1 (en) | 2008-08-11 | 2010-02-18 | Conceptx Medical, Inc. | Systems and methods for treating dyspnea, including via electrical afferent signal blocking |
US10736689B2 (en) | 2008-08-20 | 2020-08-11 | Prostacare Pty Ltd | Low-corrosion electrode for treating tissue |
US8202292B2 (en) | 2008-10-13 | 2012-06-19 | Stryker Corporation | Vaso-occlusive coil delivery system |
EP2346431A4 (en) * | 2008-11-03 | 2012-10-03 | Univ Ben Gurion | Method and apparatus for thrombus dissolution/thrombectomy by an electrode catheter device |
US8652129B2 (en) | 2008-12-31 | 2014-02-18 | Medtronic Ardian Luxembourg S.A.R.L. | Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation |
WO2010080886A1 (en) | 2009-01-09 | 2010-07-15 | Recor Medical, Inc. | Methods and apparatus for treatment of mitral valve in insufficiency |
WO2010104955A2 (en) * | 2009-03-13 | 2010-09-16 | Boston Scientific Scimed, Inc. | Electrical contact for occlusive device delivery system |
JP5638601B2 (en) * | 2009-04-06 | 2014-12-10 | ストライカー コーポレイションStryker Corporation | Delivery wire for closure device delivery system |
US8398671B2 (en) * | 2009-04-16 | 2013-03-19 | Stryker Corporation | Electrical contact for occlusive device delivery system |
US20100268251A1 (en) * | 2009-04-16 | 2010-10-21 | Boston Scientific Scimed, Inc. | Delivery wire for occlusive device delivery system and method of manufacture |
US9314250B2 (en) | 2009-04-16 | 2016-04-19 | Stryker Corporation | Electrical contact for occlusive device delivery system |
US8657870B2 (en) | 2009-06-26 | 2014-02-25 | Biosensors International Group, Ltd. | Implant delivery apparatus and methods with electrolytic release |
US20110118776A1 (en) * | 2009-11-18 | 2011-05-19 | Boston Scientific Scimed, Inc. | Delivery wire assembly for occlusive device delivery system |
KR20130054952A (en) | 2010-04-14 | 2013-05-27 | 마이크로벤션, 인코포레이티드 | Implant delivery device |
US9039749B2 (en) | 2010-10-01 | 2015-05-26 | Covidien Lp | Methods and apparatuses for flow restoration and implanting members in the human body |
EP3449856B1 (en) | 2010-10-25 | 2023-06-28 | Medtronic Ardian Luxembourg S.à.r.l. | Device for evaluation and feedback of neuromodulation treatment |
US10398444B2 (en) | 2011-03-30 | 2019-09-03 | Noha, Llc | Advanced endovascular clip and method of using same |
US10028745B2 (en) | 2011-03-30 | 2018-07-24 | Noha, Llc | Advanced endovascular clip and method of using same |
US9050089B2 (en) | 2011-05-31 | 2015-06-09 | Covidien Lp | Electrosurgical apparatus with tissue site sensing and feedback control |
US11311332B2 (en) | 2011-08-23 | 2022-04-26 | Magneto Thrombectomy Solutions Ltd. | Thrombectomy devices |
EP2755574A1 (en) * | 2011-09-13 | 2014-07-23 | Stryker Corporation | Vaso-occlusive device |
US9579104B2 (en) | 2011-11-30 | 2017-02-28 | Covidien Lp | Positioning and detaching implants |
US9011480B2 (en) | 2012-01-20 | 2015-04-21 | Covidien Lp | Aneurysm treatment coils |
US8919035B2 (en) | 2012-01-27 | 2014-12-30 | Medical Energetics Ltd | Agricultural applications of a double helix conductor |
US9693816B2 (en) * | 2012-01-30 | 2017-07-04 | Covidien Lp | Electrosurgical apparatus with integrated energy sensing at tissue site |
US8652023B2 (en) * | 2012-02-13 | 2014-02-18 | Lifewave, Inc. | Health applications of a double helix conductor |
US9750568B2 (en) | 2012-03-08 | 2017-09-05 | Medtronic Ardian Luxembourg S.A.R.L. | Ovarian neuromodulation and associated systems and methods |
WO2013134733A2 (en) | 2012-03-08 | 2013-09-12 | Medtronic Ardian Luxembourg Sarl | Biomarker sampling in the context of neuromodulation devices and associated systems and methods |
US9687245B2 (en) | 2012-03-23 | 2017-06-27 | Covidien Lp | Occlusive devices and methods of use |
DE112013002175T5 (en) | 2012-04-24 | 2015-01-22 | Cibiem, Inc. | Endovascular catheters and procedures for ablation of the carotid body |
US8749333B2 (en) | 2012-04-26 | 2014-06-10 | Lifewave, Inc. | System configuration using a double helix conductor |
EP2854681A4 (en) | 2012-06-01 | 2016-02-17 | Cibiem Inc | Percutaneous methods and devices for carotid body ablation |
US9402677B2 (en) | 2012-06-01 | 2016-08-02 | Cibiem, Inc. | Methods and devices for cryogenic carotid body ablation |
US10028786B2 (en) | 2012-06-29 | 2018-07-24 | Covidien Lp | Helical connector assembly |
US9283033B2 (en) | 2012-06-30 | 2016-03-15 | Cibiem, Inc. | Carotid body ablation via directed energy |
US9326774B2 (en) | 2012-08-03 | 2016-05-03 | Covidien Lp | Device for implantation of medical devices |
US9649146B2 (en) | 2012-10-02 | 2017-05-16 | Covidien Lp | Electro-thermal device |
US20140110296A1 (en) | 2012-10-19 | 2014-04-24 | Medtronic Ardian Luxembourg S.A.R.L. | Packaging for Catheter Treatment Devices and Associated Devices, Systems, and Methods |
US9566071B2 (en) * | 2013-04-11 | 2017-02-14 | Blockade Medical, LLC | Systems and devices for cerebral aneurysm repair |
US10076399B2 (en) | 2013-09-13 | 2018-09-18 | Covidien Lp | Endovascular device engagement |
US9724531B2 (en) | 2013-10-28 | 2017-08-08 | Medical Energetics Ltd. | Double helix conductor with light emitting fluids for producing photobiomodulation effects in living organisms |
US9636518B2 (en) | 2013-10-28 | 2017-05-02 | Medical Energetics Ltd. | Nested double helix conductors |
US20150148795A1 (en) * | 2013-11-26 | 2015-05-28 | Boston Scientific Scimed, Inc. | Radio frequency ablation coil |
US9861830B1 (en) * | 2013-12-13 | 2018-01-09 | Medical Energetics Ltd. | Double helix conductor with winding around core |
WO2015095806A2 (en) | 2013-12-20 | 2015-06-25 | Microvention, Inc. | Device delivery system |
JP2015134162A (en) * | 2014-01-10 | 2015-07-27 | クック・メディカル・テクノロジーズ・リミテッド・ライアビリティ・カンパニーCook Medical Technologies Llc | Energy-induced embolization system |
JP2017510070A (en) | 2014-03-05 | 2017-04-06 | メディカル エナジェティクス リミテッド | Double helical electrical conductor with 8 connectors and counter rotating field |
EP3116408B1 (en) | 2014-03-12 | 2018-12-19 | Cibiem, Inc. | Ultrasound ablation catheter |
US10194980B1 (en) | 2014-03-28 | 2019-02-05 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for catheter-based renal neuromodulation |
US9980766B1 (en) | 2014-03-28 | 2018-05-29 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and systems for renal neuromodulation |
US10194979B1 (en) | 2014-03-28 | 2019-02-05 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for catheter-based renal neuromodulation |
US9463331B2 (en) | 2014-04-07 | 2016-10-11 | Medical Energetics Ltd | Using a double helix conductor to treat neuropathic disorders |
AU2015201169A1 (en) | 2014-04-10 | 2015-10-29 | Medical Energetics Ltd. | Double helix conductor with counter-rotating fields |
CN106659574B (en) | 2014-04-11 | 2018-12-25 | 微仙美国有限公司 | Implantation material delivery system |
US9713475B2 (en) | 2014-04-18 | 2017-07-25 | Covidien Lp | Embolic medical devices |
US9808256B2 (en) | 2014-08-08 | 2017-11-07 | Covidien Lp | Electrolytic detachment elements for implant delivery systems |
US9814466B2 (en) | 2014-08-08 | 2017-11-14 | Covidien Lp | Electrolytic and mechanical detachment for implant delivery systems |
US10102955B2 (en) | 2015-02-20 | 2018-10-16 | Medical Energetics Ltd. | Dual double helix conductors |
US9717503B2 (en) | 2015-05-11 | 2017-08-01 | Covidien Lp | Electrolytic detachment for implant delivery systems |
WO2016198265A1 (en) | 2015-06-09 | 2016-12-15 | Medical Energetics Ltd. | Dual double helix conductors used in agriculture |
JP6868626B2 (en) | 2015-09-01 | 2021-05-12 | メディカル エナジェティックス リミテッドMedical Energetics Ltd. | Rotary dual double helix conductor |
GB2545484A (en) * | 2015-12-18 | 2017-06-21 | Cook Medical Technologies Llc | Electrochemical protection of conducting circuit in the body of a patient |
FR3047163A1 (en) * | 2016-02-01 | 2017-08-04 | Miravas | DEVICE FOR THERMAL TREATMENT OF VESSELS, AND ASSOCIATED METHOD |
US10159523B2 (en) | 2016-02-09 | 2018-12-25 | Covidien Lp | Bipolar plasma catheter |
US10828037B2 (en) | 2016-06-27 | 2020-11-10 | Covidien Lp | Electrolytic detachment with fluid electrical connection |
US10828039B2 (en) | 2016-06-27 | 2020-11-10 | Covidien Lp | Electrolytic detachment for implantable devices |
US11051822B2 (en) | 2016-06-28 | 2021-07-06 | Covidien Lp | Implant detachment with thermal activation |
US10874402B2 (en) * | 2017-10-10 | 2020-12-29 | Boston Scientific Scimed, Inc. | Detachable RF energized occlusive device |
WO2019102307A1 (en) | 2017-11-23 | 2019-05-31 | Magneto Thrombectomy Solutions Ltd. | Tubular thrombectomy devices |
KR20190001355U (en) | 2017-11-27 | 2019-06-07 | 프로스타캐어 피티와이 엘티디 | An apparatus and a method for the treatment of a prostatic disease |
US11224474B2 (en) | 2018-02-28 | 2022-01-18 | Prostacare Pty Ltd | System for managing high impedance changes in a non-thermal ablation system for BPH |
JP2022541194A (en) * | 2019-07-16 | 2022-09-22 | マイクロベンション インコーポレイテッド | Medical device with improved shape characteristics |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2839049A (en) * | 1954-03-25 | 1958-06-17 | Kenneth S Maclean | Abrasive cytologic brush |
US3789841A (en) * | 1971-09-15 | 1974-02-05 | Becton Dickinson Co | Disposable guide wire |
US3840016A (en) * | 1972-03-10 | 1974-10-08 | H Lindemann | Electrocoagulation-bougie for the intrauterine tube sterilization |
US3996938A (en) * | 1975-07-10 | 1976-12-14 | Clark Iii William T | Expanding mesh catheter |
US4030508A (en) * | 1976-02-04 | 1977-06-21 | Vitatron Medical B.V. | Low output electrode for cardiac pacing |
US4114603A (en) * | 1976-08-06 | 1978-09-19 | Wilkinson Harold A | Intracranial pressure monitoring catheter |
WO1982000768A1 (en) * | 1980-09-03 | 1982-03-18 | Taylor T | Therapeutic device |
US4585013A (en) * | 1981-04-20 | 1986-04-29 | Cordis Corporation | Lumenless pervenous electrical lead and method of implantation |
US4411648A (en) * | 1981-06-11 | 1983-10-25 | Board Of Regents, The University Of Texas System | Iontophoretic catheter device |
JPS598937A (en) * | 1982-07-08 | 1984-01-18 | 塩野義製薬株式会社 | Minute electrode and production thereof |
US4545390A (en) * | 1982-09-22 | 1985-10-08 | C. R. Bard, Inc. | Steerable guide wire for balloon dilatation procedure |
US4512338A (en) * | 1983-01-25 | 1985-04-23 | Balko Alexander B | Process for restoring patency to body vessels |
US4554929A (en) * | 1983-07-13 | 1985-11-26 | Advanced Cardiovascular Systems, Inc. | Catheter guide wire with short spring tip and method of using the same |
US4538622A (en) * | 1983-11-10 | 1985-09-03 | Advanced Cardiovascular Systems, Inc. | Guide wire for catheters |
US4567900A (en) * | 1984-06-04 | 1986-02-04 | Moore J Paul | Internal deployable defibrillator electrode |
US5019075A (en) * | 1984-10-24 | 1991-05-28 | The Beth Israel Hospital | Method and apparatus for angioplasty |
US4619274A (en) * | 1985-04-18 | 1986-10-28 | Advanced Cardiovascular Systems, Inc. | Torsional guide wire with attenuated diameter |
US4613324A (en) * | 1985-06-17 | 1986-09-23 | Ghajar Jamshid B G | Method and apparatus for guiding catheter into ventricular system of human brain |
US4660571A (en) * | 1985-07-18 | 1987-04-28 | Cordis Corporation | Percutaneous lead having radially adjustable electrode |
US4748986A (en) * | 1985-11-26 | 1988-06-07 | Advanced Cardiovascular Systems, Inc. | Floppy guide wire with opaque tip |
US4735201A (en) * | 1986-01-30 | 1988-04-05 | The Beth Israel Hospital Association | Optical fiber with detachable metallic tip for intravascular laser coagulation of arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US4723556A (en) * | 1986-04-14 | 1988-02-09 | Cordis Corporation | Intracranial ventricular catheter assembly |
US4739768B2 (en) * | 1986-06-02 | 1995-10-24 | Target Therapeutics Inc | Catheter for guide-wire tracking |
US4825880A (en) * | 1987-06-19 | 1989-05-02 | The Regents Of The University Of California | Implantable helical coil microwave antenna |
US4820298A (en) * | 1987-11-20 | 1989-04-11 | Leveen Eric G | Internal vascular prosthesis |
US4884579A (en) * | 1988-04-18 | 1989-12-05 | Target Therapeutics | Catheter guide wire |
US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
US5122136A (en) * | 1990-03-13 | 1992-06-16 | The Regents Of The University Of California | Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US5354295A (en) * | 1990-03-13 | 1994-10-11 | Target Therapeutics, Inc. | In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US5108407A (en) * | 1990-06-08 | 1992-04-28 | Rush-Presbyterian St. Luke's Medical Center | Method and apparatus for placement of an embolic coil |
US5178618A (en) * | 1991-01-16 | 1993-01-12 | Brigham And Womens Hospital | Method and device for recanalization of a body passageway |
US5542928A (en) * | 1991-05-17 | 1996-08-06 | Innerdyne, Inc. | Method and device for thermal ablation having improved heat transfer |
US5217484A (en) * | 1991-06-07 | 1993-06-08 | Marks Michael P | Retractable-wire catheter device and method |
US5226911A (en) * | 1991-10-02 | 1993-07-13 | Target Therapeutics | Vasoocclusion coil with attached fibrous element(s) |
US5246014A (en) * | 1991-11-08 | 1993-09-21 | Medtronic, Inc. | Implantable lead system |
US5486208A (en) * | 1993-02-10 | 1996-01-23 | Ginsburg; Robert | Method and apparatus for controlling a patient's body temperature by in situ blood temperature modification |
-
1995
- 1995-06-30 US US08/497,294 patent/US5851206A/en not_active Expired - Lifetime
- 1995-09-15 US US08/528,915 patent/US5919187A/en not_active Expired - Lifetime
-
1996
- 1996-06-25 CA CA002179863A patent/CA2179863C/en not_active Expired - Fee Related
- 1996-06-26 ES ES96304695T patent/ES2196123T3/en not_active Expired - Lifetime
- 1996-06-26 EP EP96304695A patent/EP0750886B1/en not_active Expired - Lifetime
- 1996-06-26 DE DE69627243T patent/DE69627243T2/en not_active Expired - Lifetime
- 1996-06-26 DK DK96304695T patent/DK0750886T3/en active
- 1996-06-26 AT AT96304695T patent/ATE236583T1/en not_active IP Right Cessation
- 1996-06-28 NO NO19962745A patent/NO321938B1/en not_active IP Right Cessation
- 1996-06-28 AU AU56244/96A patent/AU723902B2/en not_active Ceased
- 1996-06-29 KR KR1019960025711A patent/KR100437847B1/en not_active IP Right Cessation
- 1996-07-01 JP JP08171373A patent/JP3131386B2/en not_active Expired - Fee Related
- 1996-07-24 TW TW085109034A patent/TW396029B/en not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE42625E1 (en) | 1990-03-13 | 2011-08-16 | The Regents Of The University Of California | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
USRE42662E1 (en) | 1990-03-13 | 2011-08-30 | The Regents Of The University Of California | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
USRE42756E1 (en) | 1990-03-13 | 2011-09-27 | The Regents Of The University Of California | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
Also Published As
Publication number | Publication date |
---|---|
KR100437847B1 (en) | 2004-10-22 |
ATE236583T1 (en) | 2003-04-15 |
ES2196123T3 (en) | 2003-12-16 |
DE69627243D1 (en) | 2003-05-15 |
US5919187A (en) | 1999-07-06 |
AU5624496A (en) | 1997-01-09 |
EP0750886B1 (en) | 2003-04-09 |
NO962745L (en) | 1997-01-02 |
CA2179863A1 (en) | 1996-12-31 |
AU723902B2 (en) | 2000-09-07 |
EP0750886A1 (en) | 1997-01-02 |
US5851206A (en) | 1998-12-22 |
DK0750886T3 (en) | 2003-08-04 |
NO321938B1 (en) | 2006-07-24 |
TW396029B (en) | 2000-07-01 |
NO962745D0 (en) | 1996-06-28 |
JPH0998981A (en) | 1997-04-15 |
KR970000269A (en) | 1997-01-21 |
JP3131386B2 (en) | 2001-01-31 |
DE69627243T2 (en) | 2004-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2179863C (en) | Method and apparatus for endovascular thermal thrombosis and thermal cancer treatment | |
US5354295A (en) | In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas | |
CA2055492C (en) | Endovascular electrolytically detachable guidewire tip | |
US5947962A (en) | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries veins aneurysms vascular malformations and arteriovenous fistulas | |
USRE42625E1 (en) | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas | |
USRE41029E1 (en) | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20140625 |